Top ▲

Top ▲

Targets Associated with Immuno Processes - Cytokine production & signalling

Jump to: GPCR | Ion Channels | NHRs | Enzymes | Catalytic Receptors | Transporters | Other Protein Targets |

Cytokine production & signalling Download as CSV
GPCRs
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
5-HT2A receptor
(5-Hydroxytryptamine receptors)
  • positive regulation of cytokine production involved in immune response (GO:0002720) IEA
true The chemoattractant properties of 5-HT on human eosinophils is mediated by 5-HT2A receptor [61] ...
5-HT2B receptor
(5-Hydroxytryptamine receptors)
  • positive regulation of cytokine production (GO:0001819) IDA
true The expression of 5-HT2B receptors on immune cells indicates that it plays some part in immune/inflammatory responses [570] ...
ACKR1
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) IBA
  • regulation of chemokine production (GO:0032642) NAS
true ACKR1 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. Studies in ACKR1 null mice, and analysis of ACKR1 SNPs in asthmatic patients with poorly controlled symptoms, suggest a role for this cytokine receptor in the temporal regulation of asthma pathophysiology and symptoms [98] ...
ACKR2
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) IDA
  • C-C chemokine receptor activity (GO:0016493) IBA
true ACKR2 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
ACKR3
(Chemokine receptors)
  • C-C chemokine receptor activity (GO:0016493) IBA
  • C-X-C chemokine receptor activity (GO:0016494) IMP
  • chemokine-mediated signaling pathway (GO:0070098) IMP
true ACKR3 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. ACKR3 binds the chemokine CXCL12 (stromal cell-derived factor 1, SDF-1 which is also a ligand for CXCR4). ACKR3 is an atypical receptor in that it does not activate G-protein-mediated signaling but induces β-arrestin recruitment [258] ...
ACKR4
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) IDA
  • C-C chemokine receptor activity (GO:0016493) IBA
true ACKR4 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
C3a receptor
(Complement peptide receptors)
  • positive regulation of vascular endothelial growth factor production (GO:0010575) IEA
true Complement C3a receptor 1 is the receptor for complement factor C3a, a component of the alternative complement cascade. It can have pro-inflammatory actions, but can also counteract the proinflammatory effects of C5a.
The complement system plays a critical role intestinal immune homeostasis. In particular, C3 and the C3aR have been identified as being involved in regulating the intestinal immune response during chronic colitis [524,584] ...
C5a1 receptor
(Complement peptide receptors)
  • positive regulation of vascular endothelial growth factor production (GO:0010575) IEA
true C5aR is typically associated with the compement cascade and innate immunity.
MorphoSys have an anti-C5aR monoclonal antibody (MOR210; TJ210) in preclinical development as an immuno-oncology agent. The goal of anti-C5aR therapy is to reduce the effects that activation of the C5a/C5aR axis has on promoting cancer cell migration and invasiveness [230,336,397-398] ...
C5a2 receptor
(Complement peptide receptors)
  • regulation of interleukin-8 production (GO:0032677) IMP
  • negative regulation of interleukin-6 production (GO:0032715) IMP
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
true C5aR is typically associated with the compement cascade and innate immunity. However, the complement C5a receptor 2 may act as a decoy receptor for C5a, as it has no reported G protein signalling capacity.
CCR1
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) IDA
  • C-C chemokine receptor activity (GO:0016493) IDA
  • cytokine-mediated signaling pathway (GO:0019221) NAS
  • chemokine-mediated signaling pathway (GO:0070098) IDA
true CCR1 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CCR10
(Chemokine receptors)
  • C-C chemokine receptor activity (GO:0016493) IBA
true CCR10 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CCR2
(Chemokine receptors)
  • regulation of T cell cytokine production (GO:0002724) ISS
  • chemokine receptor activity (GO:0004950) TAS
  • regulation of vascular endothelial growth factor production (GO:0010574) ISS
  • C-C chemokine receptor activity (GO:0016493) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of type II interferon production (GO:0032729) ISS
  • positive regulation of interleukin-2 production (GO:0032743) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • chemokine-mediated signaling pathway (GO:0070098) IDA
true CCR2 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CCR2 is discussed in relation to immuno-oncology in [3] ...
CCR3
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IDA
  • chemokine-mediated signaling pathway (GO:0070098) IDA
true CCR3 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CCR4
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IDA
true CCR4 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
In disease states CCR4 is involved in recruiting T helper type 2 cell (Th2) subsets in autoimmune disorders such as asthma, allergic rhinitis, and atopic dermatitis [503] ...
CCR5
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IDA
true CCR5 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CCR5 is discussed in relation to immuno-oncology in [3] ...
CCR6
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IDA
true CCR6 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. CCR6 is expressed on a variety of immune cells including memory and regulatory T-cells [274,319] ...
CCR7
(Chemokine receptors)
  • C-C chemokine receptor activity (GO:0016493) ISS
  • regulation of type II interferon production (GO:0032649) ISS
  • regulation of interleukin-1 beta production (GO:0032651) ISS
  • negative regulation of interleukin-12 production (GO:0032695) ISS
  • positive regulation of interleukin-12 production (GO:0032735) ISS
  • C-C motif chemokine 19 receptor activity (GO:0038117) IDA
  • CCL19-activated CCR7 signaling pathway (GO:0038119) IDA
  • CCL21-activated CCR7 signaling pathway (GO:0038120) IDA
  • C-C motif chemokine 21 receptor activity (GO:0038121) IDA
  • cellular response to cytokine stimulus (GO:0071345) IDA
true CCR7 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CCR8
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IBA
true CCR8 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CCR9
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IBA
true CCR9 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. Activation of CCR9 by CCL25 plays a key role in leukocyte recruitment to the gut and CCR9 antagonists are being pursued as therapeutic agents for inflammatory bowel disease [585] ...
CCRL2
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IBA
true CCRL2 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. However, the nomenclature of CCLR2 for this receptor and its classification as a member of the chemokine receptor family is prov ...
chemerin receptor 1
(Chemerin receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • negative regulation of interleukin-12 production (GO:0032695) ISS
true Studies in CMKLR1 (chemerin receptor 1) knockout mice highlight the role of this receptor in inflammation and obesity. Chemerin receptor 1 is activated by the lipid-derived, anti-inflammatory autacoid ligand resolvin E1. As its name suggests, reslovin E1 is involved in resolving physiological inflammatory responses. The metabolically stable resolvin E1 analogue, RX-10045 (navamepent) has completed Phase 2 clinical trials in several occular inflammation indications. In relation to multiple sclerosis (MS), clinical EAE is significantly reduced in CMKLR1 KO mice. Taking this in to consideration with data that confirm CMKLR1 expression by the main effector cells in MS, this protein is judged to be a novel and tractable target for therapeutic intervention in MS. CMKLR1 antagonists are being pursued as anti-inflammatory agents. The selective CMKLR1 antagonist CCX832 was developed by ChemoCentryx and GlaxoSmithKline as a potential anti-psoriatic medication, but development appears to have halted at Phase 1. is a CMKLR1 antagonist that has shown efficacious effects applicable to MS in vitro and in vivo [193] ...
CXCR1
(Chemokine receptors)
  • interleukin-8 receptor activity (GO:0004918) IDA
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IBA
true CXCR1 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CXCR1 is discussed in relation to immuno-oncology in [3] ...
CXCR2
(Chemokine receptors)
  • interleukin-8 receptor activity (GO:0004918) IDA
  • C-C chemokine receptor activity (GO:0016493) IBA
  • C-X-C chemokine receptor activity (GO:0016494) IDA
  • interleukin-8-mediated signaling pathway (GO:0038112) IDA
true CXCR2 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CXCR2 is discussed in relation to immuno-oncology in [3] ...
CXCR3
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IDA
  • C-X-C chemokine receptor activity (GO:0016494) IEA
true CXCR3 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CXCR3 is the receptor for CXCL9, -10 and -11, three CXC chemokines that are preferentially expressed on Th1 lymphocytes.

In the cancer setting cytokines are known to establish an immunosuppressive milieu that is condusive to tumour progression. CXCR3 and its ligands have specifically been identified as being associated with this mechanism in pancreatic ductal adenocarcinoma [81] ...
CXCR4
(Chemokine receptors)
  • C-C chemokine receptor activity (GO:0016493) IBA
  • C-X-C chemokine receptor activity (GO:0016494) IDA
  • C-X-C motif chemokine 12 receptor activity (GO:0038147) IDA
  • CXCL12-activated CXCR4 signaling pathway (GO:0038160) IDA
  • cellular response to cytokine stimulus (GO:0071345) IDA
  • positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448) IMP
true CXCR4 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. Due to its role in cancer cell homing and metastasis the CXCR4-CXCL12 axis is a potential target for cancer therapy [451,478,566,575] ...
CXCR5
(Chemokine receptors)
  • C-C chemokine receptor activity (GO:0016493) IBA
  • C-X-C chemokine receptor activity (GO:0016494) IEA
true CXCR5 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CXCR6
(Chemokine receptors)
  • C-C chemokine receptor activity (GO:0016493) IBA
  • C-X-C chemokine receptor activity (GO:0016494) IEA
true CXCR6 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CXCR6 is upregulated by IL-2 and IL-15 [551] ...
CX3CR1
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IBA
  • C-X3-C chemokine receptor activity (GO:0016495) IDA
  • regulation of tumor necrosis factor production (GO:0032680) ISS
  • negative regulation of interleukin-1 beta production (GO:0032691) ISS
true CX3CR1 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
D2 receptor
(Dopamine receptors)
  • positive regulation of glial cell-derived neurotrophic factor production (GO:1900168) IDA
true D2 receptor-mediated anti-inflammatory effects in the kidney have a protective effect. In contrast, impaired D2 receptor function results in renal inflammation and organ damage [626] ...
EP4 receptor
(Prostanoid receptors)
  • negative regulation of cytokine production (GO:0001818) ISS
  • positive regulation of cytokine production (GO:0001819) ISS
true The EP4 prostanoid receptor is one of four receptor subtypes for prostaglandin PGE2. The anti- and pro-inflammatory (and non-inflammatory) activities of this receptor are reviewed in [611] ...
FFA1 receptor
(Free fatty acid receptors)
  • negative regulation of interleukin-1 beta production (GO:0032691) IMP
true Studies in Ffar1 (Gpr40) knockout mice indicate that it plays a protective role in fibrotic kidney disease models [176] ...
FFA2 receptor
(Free fatty acid receptors)
  • positive regulation of cytokine production involved in immune response (GO:0002720) ISS
  • positive regulation of chemokine production (GO:0032722) ISS
  • positive regulation of interleukin-8 production (GO:0032757) IMP
true FFAR2 is a GPCR activated by short-chain fatty acids, and evidence suggests that FFAR2 (and FFAR3) mediate beneficial effects associated with a fiber-rich diet. These GPCRs are of interest as targets for the treatment of inflammatory and metabolic diseases. FFAR2 is included in GtoImmuPdb as it is highly expressed on immune cells, in particular neutrophils, and evidence points to a role in diseases with dysfunctional neutrophil responses, such as inflammatory bowel disease (IBD). A Phase 2 trial of the clinical candidate GLPG0974 in ulcerative colitis has been completed (see NCT0182932).
In vitro and in vivo studies suggest that the short-chain fatty acid/FFAR2 axis is modulated by metabolites of cholera toxin, that are produced by gut microbiota, which leads to enhanced mucosal antibody responses against enteric pathogen infection [605] ...
FFA3 receptor
(Free fatty acid receptors)
  • positive regulation of cytokine production involved in immune response (GO:0002720) ISS
  • positive regulation of chemokine production (GO:0032722) ISS
true FFA3 has been included in GtoImmuPdb as its expression has been detected in immune cells [68] ...
FFA4 receptor
(Free fatty acid receptors)
  • negative regulation of cytokine production (GO:0001818) ISS
  • negative regulation of interleukin-1 beta production (GO:0032691) IMP
true FFA4 has been identified as a drug target in asthma and COPD [443] ...
GPR35
(Class A Orphans with emerging pharmacology)
  • chemokine receptor activity (GO:0004950) IDA
  • C-X-C chemokine receptor activity (GO:0016494) IMP
  • chemokine-mediated signaling pathway (GO:0070098) IDA
true GPR35 is expressed by dendritic cells, macrophages, and granulocytes, all of which show chemotactic response to CXCL17 [434] ...
GPR65
(Class A Orphans with emerging pharmacology)
  • positive regulation of interleukin-22 production (GO:0032746) ISS
true Tha expression profile of GPR65 suggests an immunological role. In addition, disruption of GPR65 expression leads to reduced eosinophilia in models of allergic airway disease [278] ...
MAS1
(Mas1, BB3/Brs3, GPR17)
  • C-C chemokine receptor activity (GO:0016493) IDA
  • chemokine-mediated signaling pathway (GO:0070098) IDA
true Experimental evidence from animal studies suggest a role for MAS1 in the anti-inflammatory pathway mediated by angiotensin-(1-7) [129,154] ...
MRGPRX2
(Class A Orphans with emerging pharmacology)
  • positive regulation of cytokine production (GO:0001819) ISS
  • C-C chemokine receptor activity (GO:0016493) IDA
  • positive regulation of chemokine production (GO:0032722) ISS
  • chemokine-mediated signaling pathway (GO:0070098) IDA
true Expression of MRGPRX2 was initially reported predominantly in sensory neurons of the dorsal root ganglion. More recently expression has been detected in human mast cells. In these cells the receptor is activated by the antimicrobial peptide LL-37, resulting in calcium mobilisation and degranulation [356,518] ...
PAR1
(Proteinase-activated receptors)
  • regulation of interleukin-1 beta production (GO:0032651) ISS
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
true PAR1 has been found to mediate the effects of neutrophil elastase (NE) on γδ T cell activation, as the PAR1 inhibitor abrogates NE (from neutrophils)-induced activation of these T cells [543] ...
PAR2
(Proteinase-activated receptors)
  • positive regulation of cytokine production involved in immune response (GO:0002720) IDA
  • negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) IDA
  • negative regulation of chemokine production (GO:0032682) IDA
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of type II interferon production (GO:0032729) ISS
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-10 production (GO:0032733) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • negative regulation of toll-like receptor 3 signaling pathway (GO:0034140) IMP
  • positive regulation of toll-like receptor 3 signaling pathway (GO:0034141) IMP
  • regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341) IDA
true PAR2 receptors have been reported to elicit pain and inflammation through a neurogenic mechanism of action, causing release of substance P, activation of NK1 receptors, and sensitization of TRPV1 voltage-gated ion channels. This action can be negated using a selective NK1 receptor antagonist (L732,138) or a TRPV1 receptor antagonist (capsazepine) [181] ...
XCR1
(Chemokine receptors)
  • chemokine receptor activity (GO:0004950) TAS
  • C-C chemokine receptor activity (GO:0016493) IBA
true XCR1 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. XCR1 is expressed by a subset of dendritic cells [304] ...
Ion Channels
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
nicotinic acetylcholine receptor α7 subunit
(Nicotinic acetylcholine receptors (nACh))
  • negative regulation of tumor necrosis factor production (GO:0032720) IDA
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) IDA
true Included in Guide to Immunopharmacology as CHRNA7 knockout aggravates rheumatoid arthritis in mice [555] ...
P2X7
(P2X receptors)
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) ISS
true The P2X7 receptor is involved in NLRP3-type inflammasome formation, and subsequent maturation of IL-1β [322,452] ...
TRPM4
(Transient Receptor Potential channels (TRP))
  • regulation of T cell cytokine production (GO:0002724) IDA
true TRPM4 is expressed on human T cells, mouse dendritic cells, human and mouse monocytes/macrophages, and mouse mast cells [421] ...
TRPV4
(Transient Receptor Potential channels (TRP))
  • positive regulation of interleukin-6 production (GO:0032755) IEA
  • positive regulation of monocyte chemotactic protein-1 production (GO:0071639) IEA
  • positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642) IEA
  • positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651) IEA
  • positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340) IEA
true Expressed on mouse neutrophils [421] ...
Nuclear Hormone Receptors
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
Farnesoid X receptor
(1H. Liver X receptor-like receptors)
  • negative regulation of type II interferon production (GO:0032689) IDA
  • negative regulation of tumor necrosis factor production (GO:0032720) IDA
  • positive regulation of interleukin-17 production (GO:0032740) IDA
  • negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) IEA
  • negative regulation of interleukin-1 production (GO:0032692) IEA
  • negative regulation of interleukin-2 production (GO:0032703) IEA
  • negative regulation of interleukin-6 production (GO:0032715) IEA
  • toll-like receptor 9 signaling pathway (GO:0034162) IEA
  • negative regulation of monocyte chemotactic protein-1 production (GO:0071638) IEA
true FXR is predominantly expressed in liver, intestine, kidney and adipose tissue, but has also been detected in immune cells (CD4+, CD8+, CD19+ and CD14+ cells) [484] ...
Liver X receptor-α
(1H. Liver X receptor-like receptors)
  • negative regulation of type II interferon-mediated signaling pathway (GO:0060336) NAS
true Liver X receptors (LXR) are involved in the regulation of lipid metabolism and inflammatory responses. As such they are novel drug targets for cholesterol homeostasis (hypercholesterolaemia), inflammation, and with potential therapeutic effects in neurodegenerative diseases [598] ...
Liver X receptor-β
(1H. Liver X receptor-like receptors)
  • negative regulation of type II interferon-mediated signaling pathway (GO:0060336) NAS
true Liver X receptors are involved in the regulation of lipid metabolism and inflammatory responses. LXRs are drug targets for cholesterol homeostasis (hypercholesterolaemia), inflammation, and with therapeutic potential in neurodegenerative diseases [598] ...
Peroxisome proliferator-activated receptor-γ
(1C. Peroxisome proliferator-activated receptors)
  • negative regulation of type II interferon-mediated signaling pathway (GO:0060336) IMP
true PPARγ agonists have anti-inflammatory effects. Full PPARγ agonists can cause undesireable weight gain, but partial agonists are devoid of this adverse effect and retain the anti-inflammatory effects of PPARγ modulation.
The PPARγ agonist boosts the inflammatory phenotype of microglia and enhances their phagocytic capacity [292] ...
Enzymes
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
5-LOX
(Lipoxygenases)
  • regulation of cytokine production involved in inflammatory response (GO:1900015) ISS
true 5-LOX is included in GtoImmuPdb because of its involvement in eicosanoid turnover and because it is being actively pursued as a molecular target for the development of novel anti-inflammatory therapeutics [499] ...
aconitate decarboxylase 1
(Itaconate biosynthesis)
  • negative regulation of type I interferon production (GO:0032480) ISS
  • cellular response to interferon-beta (GO:0035458) ISS
  • cellular response to type II interferon (GO:0071346) ISS
  • cellular response to interleukin-1 (GO:0071347) ISS
  • cellular response to tumor necrosis factor (GO:0071356) ISS
true Itaconate (itaconic acid) is generated from the citric acid (TCA) cycle intermediate cis-aconitic acid which is produced by mitochondria. Itaconate is synthesised by the enzyme aconitate decarboxylase 1 (referred to as immunoresponsive gene 1 or IRG1). Its synthesis links metabolism to immunity and it plays an important role in the macrophage-based immune response [116,146] ...
ADAM10
(M12: Astacin/Adamalysin)
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • response to tumor necrosis factor (GO:0034612) IDA
  • positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265) IDA
true ADAM10 has been identified as the primary physiologically relevant sheddase responsible for cleavage of , and regulation of ICOS/ICOSL-dependent immune responses [332] ...
ADAM17
(M12: Astacin/Adamalysin)
  • positive regulation of chemokine production (GO:0032722) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • cytokine precursor processing (GO:0140447) IDA
  • positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265) IDA
true The proteolytic activity of ADAM17 (a type I transmembrane metalloproteinase; a.k.a.TNF-alpha converting enzyme or TACE) is involved in the shedding of the extracellular domains of several transmembrane proteins e.g. cytokines (TNFα), growth factors, receptors (IL-6R and TNF-R for example) and adhesion molecules. Cleavage of substrates, including TNFα, IL-6R and L-selectin, produce pro-inflammatory effects stimulating both innate and acquired immune responses. ADAM17 activity is crucial during development (ADAM17 knockout is embryonic lethal), and it has been shown that the soluble IL-6R/IL-6 complex generates agonist-like signals in a process termed IL-6 trans-signaling. The generation and maintenance of several inflammatory and autoimmune diseases is driven by IL-6 trans-signaling [92] ...
ADAM8
(M12: Astacin/Adamalysin)
  • positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309) ISS
true ADAM8 is reported to drive acute allergen-induced airway inflammation in a mouse model, and effect negated by ADAM8-deficiency (antibody-induced or gene knockout) [428] ...
Arginase I
(Arginase)
  • negative regulation of type II interferon-mediated signaling pathway (GO:0060336) IMP
  • negative regulation of T-helper 2 cell cytokine production (GO:2000552) IEA
true The role of ARG1 in immuno-oncology is reviewed in [3] ...
Arginase II
(Arginase)
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
  • regulation of interleukin-1 beta production (GO:0032651) IEA
  • negative regulation of interleukin-13 production (GO:0032696) IEA
  • negative regulation of interleukin-17 production (GO:0032700) IEA
  • negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641) IEA
  • negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644) IEA
  • negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650) IEA
true The role of ARG2 in immuno-oncology is reviewed in [3] ...
Bruton tyrosine kinase
(Tec family)
  • regulation of B cell cytokine production (GO:0002721) TAS
  • positive regulation of cGAS/STING signaling pathway (GO:0141111) IDA
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
  • negative regulation of interleukin-10 production (GO:0032693) IEA
  • positive regulation of interleukin-6 production (GO:0032755) IEA
  • positive regulation of tumor necrosis factor production (GO:0032760) IEA
  • positive regulation of interleukin-17A production (GO:0150153) IEA
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [47] ...
casein kinase 2, beta polypeptide subunit
(Casein kinase 2 (CK2) family)
  • adiponectin-activated signaling pathway (GO:0033211) IDA
true CSNK2B is included in Guide to IMMUNOPHARMACOLOGY as it is a subunit of the casein kinase 2 complex.
Caspase 1
(C14: Caspase)
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-18 production (GO:0032741) IDA
  • cellular response to type II interferon (GO:0071346) IMP
  • cytokine precursor processing (GO:0140447) IGI
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
  • positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265) IMP
true Caspase 1 is also known as interleukin-1beta (IL-1α) converting enzyme (ICE). Amongst its substrates are the precursors of the inflammatory cytokines IL-1β and IL-18, which it proteolytically cleaves into active mature peptides.
Caspase 3
(C14: Caspase)
  • negative regulation of cytokine production (GO:0001818) IMP
  • response to tumor necrosis factor (GO:0034612) TAS
true Defective caspase 3 expression in immune effector cells may influence susceptibility to Kawasaki disease, an acute vasculitis syndrome affecting small- and medium-sized arteries of infants and children [414] ...
Caspase 4
(C14: Caspase)
  • positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265) IDA
  • positive regulation of interleukin-18-mediated signaling pathway (GO:2000494) IDA
true Recognition of cytoplasmic lipopolysaccharide (LPS) by Inflammatory caspases including caspases-4 and -5 leads to pyroptosis and secretion of inflammatory mediators [492-493] ...
Caspase 8
(C14: Caspase)
  • regulation of cytokine production (GO:0001817) ISS
  • regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) TAS
  • positive regulation of interleukin-1 beta production (GO:0032731) IMP
  • response to tumor necrosis factor (GO:0034612) IMP
true Roles of apoptotic caspases extending beyond cell death, for example, mediating cellular immune processes such as inflammasome modulation, necroptosis and pro-inflammatory cytokine processing have been reported [338] ...
cathepsin G
(S1: Chymotrypsin)
  • cytokine-mediated signaling pathway (GO:0019221) TAS
true Cathepsin G is a leukocyte serine protease of the chymotrypsin family, related to neutrophil elastase and the granzymes. It is stored in azurophil granules and acts intracellularly to degrade ingested host pathogens and axtracellularly to breakdown ECM components at sites of inflammation. Cathepsin ...
chitinase acidic
(Chitinases)
  • positive regulation of chemokine production (GO:0032722) IDA
true AMCase has been shown to be produced during type 2 inflammatory responses [633] ...
chymase 1
(S1: Chymotrypsin)
  • cytokine precursor processing (GO:0140447) IDA
true Chymase is a chymotrypsin-like serine protease that is expressed by mast cells. Amongst its activities, chymase is involved in the conversion of angiotensin (AT) I to ATII, its protease activity cleaves latent TGFβ1 and IL-1β in the cellular environment to generate the active cytokines, and it can further stimulate mast cell degranulation in a self-amplification loop. The potential of chymase as a drug target for inflammatory and gastrointestinal disorders is reviewed by Heuston and Hyland (2012) [222] ...
coagulation factor III, tissue factor
(Blood coagulation components)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • positive regulation of interleukin-8 production (GO:0032757) IMP
true
component of inhibitor of nuclear factor kappa B kinase complex
(IKK family)
  • positive regulation of interferon-alpha production (GO:0032727) IMP
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IMP
  • cellular response to tumor necrosis factor (GO:0071356) IDA
true Ikkα is one of the catalytic subunits of the IκB kinase (IKK) complex, an upstream component of the NF-κB signal transduction cascade; NF-κB signaling being involved in propagating the cellular response to inflammation. IKK frees NF-κB from its inhibitory interaction with IκBα (inhibitor of kappa B), allowing NF-κB translocation to the nucleus where it modulates transcriptional activity. Additional functions of Ikkα beyond NF-κB activation are reviewed in [231] ...
COX-2
(Cyclooxygenase)
  • positive regulation of vascular endothelial growth factor production (GO:0010575) ISS
  • positive regulation of transforming growth factor beta production (GO:0071636) ISS
  • positive regulation of fibroblast growth factor production (GO:0090271) ISS
  • positive regulation of platelet-derived growth factor production (GO:0090362) ISS
true The cyclooxygenase enzymes are included in GtoImmuPdb as they are involved in the production of inflammatory mediators, and are long-standing anti-inflammatory drug targets. The role of COX-2 in immuno-oncology is reviewed in [3] ...
C-terminal Src kinase
(Csk family)
  • negative regulation of interleukin-6 production (GO:0032715) IEA
true CSK is an inhibitory regulator of Src family kinases, a family of protein tyrosine kinases indispensable to the initiation of signal transduction via ITAM-bearing immunoreceptors, and cytokine, growth factor, and pattern recognition receptor signalling. CSK phosphorylates an inhibitory tyrosine residue at the C terminus of Src kinases, leading to autoinhibition. CSK-induced Src kinase inhibition can also be mediated by binding to PEST family receptor tyrosine phosphatases [559] ...
CTP synthase 1
(Nucleotide turnover)
  • negative regulation of type I interferon production (GO:0032480) ISS
true CTPS1 is critical for the proliferation of lymphoid cells [346] ...
cyclic GMP-AMP synthase
(Cyclic GMP-AMP turnover)
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) IDA
  • positive regulation of type I interferon production (GO:0032481) IDA
  • cGAS/STING signaling pathway (GO:0140896) IDA
true Cyclic GMP-AMP synthase (cGAS) directly binds to cytosolic DNA, and in response catalyses the synthesis of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). Thus cGAS acts as a sensor of DNA in the cytoplasm, which is an indicator of pathogen invasion [521] ...
D-dopachrome tautomerase
(Macrophage migration inhibitory factor (MIF) family proteins)
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
true D-dopachrome tautomerase has cytokine-like activity, acting as a homologue [360-361] ...
dual oxidase 1
(NADPH oxidases)
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IMP
true DUOX1 participates in innate immune responses to epithelial injury and allergens, and in the development of allergic diseases [553] ...
elastase, neutrophil expressed
(S1: Chymotrypsin)
  • negative regulation of chemokine production (GO:0032682) IDA
  • negative regulation of interleukin-8 production (GO:0032717) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
true Neutrophil elastase (NE) is a serine proteinase with broad substrate specificity. It is stored in azurophil granules within neutrophils and is involved primarily in host defence. However, in addition to attacking proteins on invading microorganisms, secreted NE also hydrolyzes proteins of the host extracellular matrix, such as collagen-IV and elastin, hence its role in degenerative and inflammatory diseases. NE functions as a promoter of γδ T cell activation via a protease-activated receptor (PAR1)-dependent mechanism [543] ...
enhancer of zeste 2 polycomb repressive complex 2 subunit
(Histone methyltransferases (HMTs))
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) IEA
true EZH2 is involved in hematopoietic stem cell proliferation and differentiation, thymopoiesis and lymphopoiesis, with notable participation in regulating the differentiation and function of T cells. This role suggests potential applications in immune-mediated conditions, including autoimmune disorders [545] ...
eukaryotic translation initiation factor 2 alpha kinase 2
(Other PEK family kinases)
  • positive regulation of cytokine production (GO:0001819) ISS
  • positive regulation of chemokine production (GO:0032722) ISS
  • response to interferon-alpha (GO:0035455) IDA
  • regulation of NLRP3 inflammasome complex assembly (GO:1900225) ISS
true Protein kinase-R (EIF2AK2) is activated by virally-introduced double-stranded RNA (dsRNA), and is therefore involved in protection against viral infection. Protein activator of the interferon-induced protein kinase EIF2AK2 (PACT; PRKRA) also activates protein kinase-R. Activated protein kinase-R phosphorylates the eukaryotic translation initiation factor eIF2α inhibiting viral protein synthesis [180] ...
FER tyrosine kinase
(Fer family)
  • cytokine-mediated signaling pathway (GO:0019221) IMP
  • cellular response to macrophage colony-stimulating factor stimulus (GO:0036006) IMP
  • Kit signaling pathway (GO:0038109) ISS
  • interleukin-6-mediated signaling pathway (GO:0070102) IMP
true FER acts downstream of the activated high affinity immunoglobulin epsilon receptor (FCεR1) and plays a role in FCεR1-mediated signaling in mast cells, regulation of mast cell degranulation, leukocyte recruitment, and leukocyte extravasation following bacterial lipopolysaccharide (LPS ...
FGR proto-oncogene, Src family tyrosine kinase
(Src family)
  • positive regulation of cytokine production (GO:0001819) ISS
true Fgr may be involved in neutrophil migration, potentially via binding to intergrins [39] ...
glycogen synthase kinase 3 beta
(GSK subfamily)
  • positive regulation of type I interferon production (GO:0032481) ISS
  • cellular response to interleukin-3 (GO:0036016) ISS
true GSK3β plays an essential function in T cell differentiation and proliferation, and its activity is inhibited following antigen-driven T cell activation [52-53,330,409] ...
Haem oxygenase 1
(Haem oxygenase)
  • positive regulation of chemokine production (GO:0032722) TAS
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) ISS
true Heme oxygenase (HO) is a rate-limiting enzyme in the catabolism of heme, catalyzing the oxidative cleavage of heme (Fe-protoporphyrin-IX) to render equimolar amounts of biliverdin, ferrous iron (Fe2+), and carbon monoxide (CO).

Heme oxygenase 1 (HO1) is a Nrf2-regulated gene, whose expression is upregulated as a cytoprotective mechanism in response to cellular stresses including inflammation, ischemia, hypoxia, hyperoxia, hyperthermia, or radiation.

HO1 has antioxidant, antiinflammatory, antiapoptotic, antiproliferative, and immunomodulatory effects in vascular cells, playing an important role in the prevention of vascular inflammation and atherogenesis (reviewed in [23] ...
HCK proto-oncogene, Src family tyrosine kinase
(Src family)
  • cytokine-mediated signaling pathway (GO:0019221) TAS
  • type II interferon-mediated signaling pathway (GO:0060333) TAS
true Hck is thought to be involved in neutrophil migration, potentially via binding to intergrins [39] ...
heparanase
(Glycosidases)
  • positive regulation of vascular endothelial growth factor production (GO:0010575) IDA
true Heparanase has been studied as a novel drug target associated with the immune response and inflammation [96-97] ...
IL2 inducible T cell kinase
(Tec family)
  • positive regulation of cytokine production (GO:0001819) ISS
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [47] ...
Inducible NOS
(Nitric oxide synthases)
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • regulation of cytokine production involved in inflammatory response (GO:1900015) IDA
true The role of iNOS in immuno-oncology is reviewed in [3] ...
inhibitor of nuclear factor kappa B kinase subunit beta
(IKK family)
  • regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) TAS
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IMP
  • toll-like receptor 3 signaling pathway (GO:0034138) TAS
  • interleukin-1-mediated signaling pathway (GO:0070498) IMP
  • cellular response to tumor necrosis factor (GO:0071356) IDA
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) IDA
true Iκβ kinase β (IKK-2) is the pivotal enzyme component of the Iκβ kinase (IKK) complex, a complex crucial in regulating expression and activation of inflammatory mediators in airway epithelium. IKK-2 is an attractive target for development of pharmaceutical inhibitors with antiinflammatory action as treatments for asthma and chronic obstructive pulmonary disease (COPD) [43,59,504] ...
inhibitor of nuclear factor kappa B kinase subunit epsilon
(IKK family)
  • positive regulation of type I interferon production (GO:0032481) IDA
  • response to interferon-beta (GO:0035456) IMP
  • type I interferon-mediated signaling pathway (GO:0060337) NAS
  • positive regulation of type I interferon-mediated signaling pathway (GO:0060340) IDA
  • interleukin-17-mediated signaling pathway (GO:0097400) IEA
true IKKε is the only inducible IKK family member. Expression is induced in response to LPS, viral infection and several cytokines. IKKε expression is restricted to pancreas, thymus, spleen and peripheral blood leukocytes. This is in contrast to all other IKK family kinases which are cons ...
interleukin 1 receptor associated kinase 1
(Interleukin-1 receptor-associated kinase (IRAK) family)
  • regulation of cytokine-mediated signaling pathway (GO:0001959) IMP
  • positive regulation of type I interferon production (GO:0032481) IMP
  • toll-like receptor 9 signaling pathway (GO:0034162) IMP
  • interleukin-33-mediated signaling pathway (GO:0038172) IMP
  • NLRP3 inflammasome complex assembly (GO:0044546) NAS
  • type I interferon-mediated signaling pathway (GO:0060337) IMP
  • interleukin-1-mediated signaling pathway (GO:0070498) IDA
  • response to interleukin-1 (GO:0070555) IMP
true One of the two proximal mediators of IL-1 signaling via the IL-1 receptor, plays a part in IL-1-induced upregulation of the transcription factor NF-κB, the other being IRAK2. Interacts with other proteins including TRAF6, Myd88, CHUK, IKK2 and TLR4.
interleukin 1 receptor associated kinase 2
(Interleukin-1 receptor-associated kinase (IRAK) family)
  • regulation of cytokine-mediated signaling pathway (GO:0001959) IMP
  • NLRP3 inflammasome complex assembly (GO:0044546) NAS
  • interleukin-1-mediated signaling pathway (GO:0070498) IMP
  • response to interleukin-1 (GO:0070555) IMP
true IRAK2 is one of the proximal mediators of IL-1 signalling via the IL-1 receptor, the other being IRAK1. It plays a part in IL-1-induced upregulation of the transcription factor NF-κB. IRAK2 interacts with TRAF6 and Myd88.
interleukin 1 receptor associated kinase 3
(Interleukin-1 receptor-associated kinase (IRAK) family)
  • negative regulation of cytokine-mediated signaling pathway (GO:0001960) IC
  • negative regulation of macrophage cytokine production (GO:0010936) ISS
  • cytokine-mediated signaling pathway (GO:0019221) ISS
  • negative regulation of interleukin-12 production (GO:0032695) IMP
  • negative regulation of interleukin-6 production (GO:0032715) IMP
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
  • interleukin-1-mediated signaling pathway (GO:0070498) IMP
  • response to interleukin-1 (GO:0070555) IMP
  • positive regulation of cytokine production (GO:0001819) IEA
true IRAK3 expression is restricted to monocytes and macrophages.
interleukin 1 receptor associated kinase 4
(Interleukin-1 receptor-associated kinase (IRAK) family)
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • toll-like receptor 9 signaling pathway (GO:0034162) IMP
  • interleukin-33-mediated signaling pathway (GO:0038172) IDA
  • NLRP3 inflammasome complex assembly (GO:0044546) NAS
  • interleukin-1-mediated signaling pathway (GO:0070498) IDA
true IRAK4 is essential for most innate immune responses to bacteria and viruses, and IRAK4 deficiency (caused by mutations) has been shown to result in recurrent invasive pneumococcal disease [357] ...
Janus kinase 1
(Janus kinase (JakA) family)
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • interleukin-15-mediated signaling pathway (GO:0035723) IDA
  • interleukin-4-mediated signaling pathway (GO:0035771) IDA
  • interleukin-5-mediated signaling pathway (GO:0038043) NAS
  • interleukin-2-mediated signaling pathway (GO:0038110) IDA
  • interleukin-7-mediated signaling pathway (GO:0038111) IC
  • interleukin-9-mediated signaling pathway (GO:0038113) IDA
  • interleukin-11-mediated signaling pathway (GO:0038154) IDA
  • oncostatin-M-mediated signaling pathway (GO:0038165) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) IDA
  • type I interferon-mediated signaling pathway (GO:0060337) IDA
  • interleukin-6-mediated signaling pathway (GO:0070102) IDA
  • ciliary neurotrophic factor-mediated signaling pathway (GO:0070120) IDA
  • interleukin-10-mediated signaling pathway (GO:0140105) IDA
true The JAK1 tyrosine kinase is crucial for signaling of certain type I and type II cytokines, via receptors belonging to the IL-2, IL-4 and IL-6 receptor families as well as neurotrophin-1 and leptin receptors (all type I cytokine receptors). JAK1 is also involved in signalling via type I ...
Janus kinase 2
(Janus kinase (JakA) family)
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of interleukin-1 beta production (GO:0032731) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IDA
  • response to tumor necrosis factor (GO:0034612) IDA
  • interleukin-12-mediated signaling pathway (GO:0035722) IDA
  • interleukin-5-mediated signaling pathway (GO:0038043) IDA
  • interleukin-23-mediated signaling pathway (GO:0038155) IDA
  • interleukin-3-mediated signaling pathway (GO:0038156) IDA
  • granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157) IDA
  • erythropoietin-mediated signaling pathway (GO:0038162) IDA
  • thrombopoietin-mediated signaling pathway (GO:0038163) IDA
  • oncostatin-M-mediated signaling pathway (GO:0038165) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) TAS
  • interleukin-6-mediated signaling pathway (GO:0070102) TAS
  • ciliary neurotrophic factor-mediated signaling pathway (GO:0070120) IDA
  • response to interleukin-12 (GO:0070671) IDA
  • interleukin-35-mediated signaling pathway (GO:0070757) TAS
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) ISS
true JAK2 signal transduction is a critical mediator of the immune response and is implicated in autoimmune conditions and in graft-versus-host disease (GvHD). The pro-inflammatory effects of IL-6, IL-12, and IL-23 on T cells are mediated via JAK2 [49,51,511] ...
Janus kinase 3
(Janus kinase (JakA) family)
  • negative regulation of dendritic cell cytokine production (GO:0002731) ISS
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • negative regulation of interleukin-10 production (GO:0032693) ISS
  • negative regulation of interleukin-12 production (GO:0032695) ISS
  • interleukin-15-mediated signaling pathway (GO:0035723) IDA
  • interleukin-4-mediated signaling pathway (GO:0035771) IDA
  • interleukin-2-mediated signaling pathway (GO:0038110) IDA
  • interleukin-7-mediated signaling pathway (GO:0038111) IDA
  • interleukin-9-mediated signaling pathway (GO:0038113) IDA
  • response to interleukin-2 (GO:0070669) TAS
  • response to interleukin-4 (GO:0070670) IDA
  • response to interleukin-15 (GO:0070672) TAS
  • response to interleukin-9 (GO:0071104) TAS
true Psoriatic skin samples show elevated JAK3 (and JAK1) expression, with signalling predominantly through STAT3 [18] ...
kynurenine 3-monooxygenase
(Kynurenine 3-monooxygenase)
  • cellular response to interleukin-1 (GO:0071347) IEA
true GSK180-induced inhibition of KMO prevents multiple organ failure in rodent models of acute pancreatitis which is caused by excessive alcohol consumption [368] ...
large tumor suppressor kinase 1
(NDR family)
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
true LATS1 and LATS2 are included in the GToImmuPdb because of their crucial role in Hipo signalling, a major mammalian signalling cascade that has recently been identified as playing an important role in shaping the innate immune response [1-2,4].
large tumor suppressor kinase 2
(NDR family)
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
true LATS1 and LATS2 are included in the GToImmuPdb because of their crucial role in Hipo signalling, a major mammalian signalling cascade that has recently been identified as playing an important role in shaping the innate immune response [1-2,4].
LYN proto-oncogene, Src family tyrosine kinase
(Src family)
  • regulation of cytokine production (GO:0001817) ISS
  • positive regulation of toll-like receptor 9 signaling pathway (GO:0034165) IDA
  • interleukin-5-mediated signaling pathway (GO:0038043) IDA
  • C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159) IMP
true LYN is a Src family tyrosine kinase, expressed predominantly in hematopoietic cells, but also in neural, liver, and adipose tissues. LYN appears to function as a rheostat to modulate B cell signaling, and can be activating or inhibitory in action, depending on the B cell receptor and interacting protein complement present in particular cells [171,179,542] ...
MALT1 paracaspase
(C14: Caspase)
  • positive regulation of T cell cytokine production (GO:0002726) IMP
  • positive regulation of interleukin-1 beta production (GO:0032731) IMP
  • positive regulation of interleukin-2 production (GO:0032743) IMP
true MALT1 inhibition is considered a tractable mechanism for the treatment of severe autoimmune diseases. The MALT1 inhibitory action of (a.k.a. mepazine) is reported to be effecacious in the mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis [355] ...
mitogen-activated protein kinase 1
(ERK subfamily)
  • interleukin-34-mediated signaling pathway (GO:0061514) IGI
  • chemokine-mediated signaling pathway (GO:0070098) ISS
true In endothelial cells of the vasculature, and in activated human mast cells, ERK serves as an anti-inflammatory signal that suppresses production of pro-inflammatory mediators [270,337] ...
mitogen-activated protein kinase 11
(p38 subfamily)
  • positive regulation of interleukin-12 production (GO:0032735) IMP
  • cellular response to interleukin-1 (GO:0071347) IDA
true p38 MAP kinases are ubiquitous, highly conserved enzymes which regulate the production of proinflammatory mediators (such as TNFα and IL-1) in response to inflammatory cytokines or environmental stress [201-202,296,429,449,573] ...
mitogen-activated protein kinase 13
(p38 subfamily)
  • positive regulation of interleukin-6 production (GO:0032755) IMP
  • cellular response to interleukin-1 (GO:0071347) IDA
true p38 MAP kinases are ubiquitous, highly conserved enzymes which regulate the production of proinflammatory mediators (such as TNFα and IL-1) in response to inflammatory cytokines or environmental stress [201-202,296,429,449,573] ...
mitogen-activated protein kinase 14
(p38 subfamily)
  • positive regulation of interleukin-12 production (GO:0032735) IMP
  • regulation of cytokine production involved in inflammatory response (GO:1900015) IDA
true p38 MAP kinases are ubiquitous, highly conserved enzymes which regulate the production of proinflammatory mediators (such as TNFα and IL-1) in response to inflammatory cytokines or environmental stress [201-202,296,429,449,573] ...
mitogen-activated protein kinase 8
(JNK subfamily)
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
true By regulating AP-1 transcriptional activity in response to cytokine activation, JNK1 contributes to the production of immunomodulators such as RANTES, IL-8 and GM-CSF .
mitogen-activated protein kinase 9
(JNK subfamily)
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IDA
true Experimental evidence suggests that JNK2 is important in T-cell differentiation [246,472,517,602] ...
mitogen-activated protein kinase kinase kinase 7
(TAK1 subfamily)
  • positive regulation of T cell cytokine production (GO:0002726) IMP
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) TAS
  • positive regulation of interleukin-2 production (GO:0032743) IMP
  • toll-like receptor 3 signaling pathway (GO:0034138) TAS
  • nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) TAS
  • interleukin-33-mediated signaling pathway (GO:0038172) IDA
  • interleukin-17A-mediated signaling pathway (GO:0038173) IDA
  • interleukin-1-mediated signaling pathway (GO:0070498) IMP
  • positive regulation of cGAS/STING signaling pathway (GO:0141111) IDA
  • cellular response to tumor necrosis factor (GO:0071356) IEA
true TAK1 (MAP3K7) mediates signaling downstream of multiple cytokine receptors and is functionally important in mitogen, immune, and inflammatory signaling pathways [131,475] ...
mitogen-activated protein kinase kinase kinase kinase 3
(KHS subfamily)
  • response to tumor necrosis factor (GO:0034612) IDA
true GLK (KHS2; MAP4K3) is ubiquitously expressed. It is involved in cellular responses to stress and inflammation [143] ...
MMP12
(M10: Matrix metallopeptidase)
  • positive regulation of interferon-alpha production (GO:0032727) IEA
  • negative regulation of type I interferon-mediated signaling pathway (GO:0060339) IEA
  • positive regulation of type I interferon-mediated signaling pathway (GO:0060340) IEA
true MMP12 is included in GtoImmuPdb based on its reported involvement in asthma and potential as a asthma therapeutic target.
MMP2
(M10: Matrix metallopeptidase)
  • cellular response to interleukin-1 (GO:0071347) IEA
true MMP2 is included in GtoImmuPdb based on its potential involvement in asthma.
MMP8
(M10: Matrix metallopeptidase)
  • positive regulation of tumor necrosis factor production (GO:0032760) IMP
  • positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265) ISS
true MMP8 is included in GtoImmuPdb based on its potential protective role in asthma.
NIMA related kinase 7
(NIMA (never in mitosis gene a)- related kinase (NEK) family)
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
true NEK7 is a component of the NLRP3 inflammasome. It is activated by deglutathionylation by glutathione transferase omega 1-1 (GSTO1-1), and this in turn promotes NLRP3 inflammasome-mediated maturation of the proinflammatory cytokines IL-1β amd IL-18 [233] ...
otulin
(C101: OTULIN peptidase)
  • regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) IDA
  • nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431) IMP
true Otulin is reported as a negative regulator of inflammation and autoimmunity [133] ...
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
(Phosphatidylinositol-4,5-bisphosphate 3-kinase family, Phosphatidylinositol kinases)
  • positive regulation of cytokine production (GO:0001819) TAS
true PI3Kδ is preferentially expressed in cells of hemopoietic lineage and is involved in neutrophil chemotaxis. It is the only PI3K isoform with expression restricted to leukocytes. Genetic and pharmacological inactivation of PI3Kδ indicates its importantance for the function of T cells, B cell, mast cells and neutrophils. PI3kδ is a promising target for drugs for preventing or treating inflammation, autoimmunity and transplant rejection [210] ...
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
(Phosphatidylinositol-4,5-bisphosphate 3-kinase family, Phosphatidylinositol kinases)
  • positive regulation of cytokine production (GO:0001819) TAS
true The role of PI3Kγ in immuno-oncology is reviewed in [3] ...
phosphodiesterase 12
(Phosphodiesterases (other))
  • cellular response to interferon-alpha (GO:0035457) IMP
  • cellular response to type II interferon (GO:0071346) IDA
true PDE12 acts as a negative regulator of a 2-5A (2′,5′-linked oligoadenylate) activated pathway of the innate interferon response to viral infection. Some RNA viruses, including coronaviruses, encode 2',5'-phosphodiesterases as a mechanism to combat their hosts' antiviral immunity [625,627] ...
phosphodiesterase 4B
(Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs))
  • positive regulation of type II interferon production (GO:0032729) IMP
  • positive regulation of interleukin-2 production (GO:0032743) IMP
true PDE4 is a drug target, whose inhibition has anti-inflammatory action. PDE4 inhibitors have already entered clinical use, being employed in the treatment of inflammatory skin conditions such as psoriatic arthritis () and atopic dermatitis (). PDE4B is the predominant phosphodiesterase subtype in monocytes and neutrophils and this is thought to be the sub-type central to inflammatory action of phosphodiesterases [569] ...
phosphodiesterase 4D
(Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs))
  • positive regulation of type II interferon production (GO:0032729) IMP
  • positive regulation of interleukin-2 production (GO:0032743) IMP
  • positive regulation of interleukin-5 production (GO:0032754) IMP
true The selective PDE4 inhibitor (OPA-15406) has been shown to inhibit PDE4D3 [410] ...
phosphoinositide-3-kinase regulatory subunit 1
(Phosphatidylinositol kinases)
  • cytokine-mediated signaling pathway (GO:0019221) IGI
  • interleukin-18-mediated signaling pathway (GO:0035655) IMP
true p85α is included in GtoImmuPdb as it is the regulatory subunit of several PI3Ks (e.g. PI3Kδ and PI3Kγ) with roles in leukocyte biology and therefore important for immunity [333] ...
phosphoinositide kinase, FYVE-type zinc finger containing
(1-phosphatidylinositol-3-phosphate 5-kinase family)
  • positive regulation of cGAS/STING signaling pathway (GO:0141111) IDA
true PIKfyve is a class III PI kinase. Evidence is revealing a crucial role for PIKfyve in Toll-like receptor (TLR) signaling via production of the cytokines IL-12 and IL-23 [78] ...
PLCγ2
(Phosphoinositide-specific phospholipase C)
  • positive regulation of dendritic cell cytokine production (GO:0002732) ISS
  • positive regulation of interleukin-10 production (GO:0032733) ISS
  • positive regulation of interleukin-12 production (GO:0032735) ISS
  • positive regulation of interleukin-2 production (GO:0032743) ISS
  • positive regulation of interleukin-23 production (GO:0032747) ISS
  • positive regulation of interleukin-6 production (GO:0032755) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • positive regulation of macrophage cytokine production (GO:0060907) ISS
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IMP
  • positive regulation of type I interferon production (GO:0032481) IEA
true Two structurally similar isoforms of PLCγ are expressed by mast cells (PLCγ1 and PLCγ2). Both are important enzymes in the integrated signalling pathways leading to mast cell activation [187,474] ...
proteasome 20S subunit beta 8
(T1: Proteasome)
  • positive regulation of type II interferon production (GO:0032729) NAS
  • positive regulation of interleukin-2 production (GO:0032743) NAS
  • positive regulation of tumor necrosis factor production (GO:0032760) NAS
  • response to type II interferon (GO:0034341) NAS
true PSMB8 is a component of the immunoproteasome [164] ...
protein kinase C alpha
(Delta subfamily)
  • response to interleukin-1 (GO:0070555) IMP
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) ISS
true PKCα is included in GtoImmuPdb based on its GO immune process associations.
protein kinase C iota
(Iota subfamily)
  • response to interleukin-1 (GO:0070555) IEA
true PKCι is included in GtoImmuPdb based on the involvement of other PKC isozymes in immune processes.
protein kinase C theta
(Delta subfamily)
  • positive regulation of interleukin-17 production (GO:0032740) ISS
  • positive regulation of interleukin-4 production (GO:0032753) ISS
true PKC-θ is a novel subfamily PKC found predominantly in hematopoietic cells [28] ...
protein kinase C zeta
(Iota subfamily)
  • positive regulation of interleukin-10 production (GO:0032733) ISS
  • positive regulation of interleukin-13 production (GO:0032736) ISS
  • positive regulation of interleukin-4 production (GO:0032753) ISS
  • positive regulation of interleukin-5 production (GO:0032754) ISS
  • positive regulation of T-helper 2 cell cytokine production (GO:2000553) ISS
true PKCζ is included in GtoImmuPdb based on its GO process associations.
protein kinase, DNA-activated, catalytic subunit
(Other PIKK family kinases)
  • negative regulation of cGAS/STING signaling pathway (GO:0160049) IDA
true Protein kinase, DNA-activated, catalytic polypeptide (DNA-PKcs) principally acts to repair DNA in a process called non-homologous end joining (NHEJ). NHEJ is required for V(D)J recombination (somatic recombination) in developing lymphocytes during the early stages of T and B cell maturation. DNA-PKc ...
protein tyrosine kinase 2 beta
(Fak family)
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IMP
  • chemokine-mediated signaling pathway (GO:0070098) ISS
true FAK and Pyk2 are phosphorylated downstream of the T cell antigen receptor (TCR) to bring about receptor-specific (e.g. chemokine and integrin receptors) T cell development and activation [99] ...
protein tyrosine phosphatase non-receptor type 1
(Protein tyrosine phosphatases non-receptor type (PTPN))
  • regulation of type I interferon-mediated signaling pathway (GO:0060338) TAS
true Inhibition of PTPN1/2 promotes T cell-mediated anti-tumour immunity [42,317,638] ...
protein tyrosine phosphatase non-receptor type 11
(Protein tyrosine phosphatases non-receptor type (PTPN))
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • negative regulation of type I interferon production (GO:0032480) IDA
  • positive regulation of interferon-beta production (GO:0032728) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • regulation of type I interferon-mediated signaling pathway (GO:0060338) TAS
true SHP2 regulates programmed cell death 1 (PD-1)-mediated signal transduction and it is therefore involved in immune checkpoint modulation.
protein tyrosine phosphatase non-receptor type 2
(Protein tyrosine phosphatases non-receptor type (PTPN))
  • negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) ISS
  • regulation of type II interferon-mediated signaling pathway (GO:0060334) TAS
  • negative regulation of type II interferon-mediated signaling pathway (GO:0060336) IMP
  • negative regulation of type I interferon-mediated signaling pathway (GO:0060339) IMP
  • negative regulation of interleukin-6-mediated signaling pathway (GO:0070104) IMP
  • negative regulation of interleukin-2-mediated signaling pathway (GO:1902206) IMP
  • negative regulation of interleukin-4-mediated signaling pathway (GO:1902215) IMP
  • negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227) ISS
true Inhibition of PTPN1/2 promotes T cell-mediated anti-tumour immunity [42,317,638] ...
protein tyrosine phosphatase non-receptor type 22
(Protein tyrosine phosphatases non-receptor type (PTPN))
  • positive regulation of type I interferon production (GO:0032481) IMP
  • negative regulation of interleukin-6 production (GO:0032715) IMP
  • negative regulation of interleukin-8 production (GO:0032717) IMP
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
  • positive regulation of type II interferon production (GO:0032729) IMP
  • positive regulation of toll-like receptor 3 signaling pathway (GO:0034141) IMP
  • negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433) IMP
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) IDA
true PTPN22 is a lymphoid-specific, inducible protein tyrosine phosphatase [114] ...
receptor interacting serine/threonine kinase 1
(Receptor interacting protein kinase (RIPK) family)
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) NAS
  • response to tumor necrosis factor (GO:0034612) IMP
  • positive regulation of interleukin-6-mediated signaling pathway (GO:0070105) IMP
  • cellular response to tumor necrosis factor (GO:0071356) IDA
  • positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265) IEA
true RIPK1 and RIPK3 are involved in necroptosis and as such are critical regulators of inflammation and cell death [392,457,497,565] ...
receptor interacting serine/threonine kinase 2
(Receptor interacting protein kinase (RIPK) family)
  • positive regulation of interferon-alpha production (GO:0032727) NAS
  • positive regulation of interferon-beta production (GO:0032728) NAS
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-12 production (GO:0032735) NAS
  • nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427) IDA
  • nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IEA
  • positive regulation of tumor necrosis factor production (GO:0032760) IEA
true RIPK2 is involved in innate immune responses, mediating pro-inflammatory signaling from the bacterial peptidoglycan-sensing NOD1/NOD2 subfamily of innate immune pattern recognition receptors (PRRs) and signalling downstream from the Toll-like receptor (TLR) family of PRRs. Further evidence suggesting an inflammatory role is the targeting of RIPK2 (along with RIPK1/3) by the IAP family E3 ubiquitin ligases (enzymes playing a critical role in innate immunity) [404] ...
receptor interacting serine/threonine kinase 3
(Receptor interacting protein kinase (RIPK) family)
  • regulation of type II interferon production (GO:0032649) ISS
true RIPK1 and RIPK3 are involved in necroptosis and as such are critical regulators of inflammation and cell death [392,457,497,565] ...
Rho associated coiled-coil containing protein kinase 2
(Rho kinase)
  • positive regulation of connective tissue growth factor production (GO:0032723) ISS
  • positive regulation of fibroblast growth factor production (GO:0090271) ISS
true ROCK2 plays a role in controlling T-cell plasticity and macrophage polarization, skewing polarization towards M1-type macrophages [619] ...
sirtuin 1
(Histone deacetylases (HDACs))
  • leptin-mediated signaling pathway (GO:0033210) ISS
  • positive regulation of macrophage cytokine production (GO:0060907) ISS
  • cellular response to tumor necrosis factor (GO:0071356) IDA
true Sirtuin 1 has been suggested as a molecular target for host-directed therapy against Mycobacterium tuberculosis infection by research that shows that activation of sirtuin 1 decreases lung pathology, reduces inflammation, and enhances drug efficacy against Mycobacterium tuberculosis [106] ...
sphingosine kinase 1
(Sphingosine kinase)
  • regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) IDA
  • positive regulation of interleukin-17 production (GO:0032740) ISS
  • response to tumor necrosis factor (GO:0034612) IDA
true The sphingosine kinases (SPHK1 and SPHK2; SK1, SK2) are key enzymes within the sphingolipid metabolism pathway that promote tumour growth and pathologic inflammation. SK1-selective inhibitors include PF-543 [481-482] ...
sphingosine kinase 2
(Sphingosine kinase)
  • positive regulation of cytokine production involved in immune response (GO:0002720) ISS
  • positive regulation of interleukin-13 production (GO:0032736) ISS
  • positive regulation of interleukin-6 production (GO:0032755) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
true The sphingosine kinases (SPHK1 and SPHK2; SK1, SK2) are key enzymes within the sphingolipid metabolism pathway that promote tumour growth and pathologic inflammation. SK2 is involved in regulating interleukin (IL)-12/interferon gamma (IFN-γ) and histone deacetylase-1/2 (HDAC-1/2) signalling, and is considered to be an anti-inflammatory enzyme with potential druggability for the treatment of autoimmune and inflammatory diseases [447] ...
sPLA2-1B
(Phospholipase A2)
  • positive regulation of interleukin-8 production (GO:0032757) ISS
true sPLA2 enzymes catalyze the first step of the arachidonic acid pathway, so are inextricably involved in the production of arachadonic acid for inflammatory mediator synthesis. Excess sPLA2 activity is suggested to contribute to several inflammatory diseases. The sPLA2-1B isozyme has been reported to induce leukotriene B4 (LTB4) production in human neutrophils, using a mechanism independent of arachadonic acid generation [293] ...
spleen associated tyrosine kinase
(Syk family)
  • regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) IMP
  • positive regulation of interleukin-10 production (GO:0032733) IMP
  • positive regulation of interleukin-12 production (GO:0032735) IMP
  • positive regulation of interleukin-4 production (GO:0032753) ISS
  • positive regulation of interleukin-6 production (GO:0032755) IMP
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IMP
  • positive regulation of toll-like receptor 9 signaling pathway (GO:0034165) IDA
  • interleukin-3-mediated signaling pathway (GO:0038156) ISS
  • positive regulation of monocyte chemotactic protein-1 production (GO:0071639) IMP
  • positive regulation of cGAS/STING signaling pathway (GO:0141111) IDA
  • positive regulation of type I interferon production (GO:0032481) IEA
true SYK plays a key role in coupling activated immunoreceptors to downstream cellular responses such as proliferation, differentiation, and phagocytosis. Mast cell, macrophage and B-cell activation (and release of inflammatory modulators) is disrupted by inhibition of SYK-mediated immunoreceptor signalling. Selective SYK inhibitors are being sought for a number of inflammatory conditions including rheumatoid arthritis, B-cell lymphoma and asthma/rhinitis [186,456] ...
SRC proto-oncogene, non-receptor tyrosine kinase
(Src family)
  • regulation of toll-like receptor 3 signaling pathway (GO:0034139) IDA
  • interleukin-6-mediated signaling pathway (GO:0070102) IDA
  • response to interleukin-1 (GO:0070555) IMP
true Src family tyrosine kinases act as general modulators of immune cell signaling, playing diverse signaling functions, both inhibitory and stimulatory, in immunoreceptor and integrin signaling pathways [331] ...
TANK binding kinase 1
(IKK family)
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) IDA
  • regulation of type I interferon production (GO:0032479) IDA
  • positive regulation of type I interferon production (GO:0032481) IDA
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • type I interferon-mediated signaling pathway (GO:0060337) NAS
  • cGAS/STING signaling pathway (GO:0140896) TAS
  • positive regulation of type I interferon-mediated signaling pathway (GO:0060340) IEA
true TBK1 belongs to the IKK-kinase family of enzymes. It is a ubiquitously expressed serine/threonine protein kinase, and constitutes a key regulatory node for several signaling pathways involved in the innate immune response that lead to induction of type I interferons. Several classes of innate sensors including the TLRs and retinoic acid-inducible gene 1 (RIG-I)-like helicases engage TBK1-IRF3 signaling pathways to regulate transcription of type I IFNs. In neuroinflammation TBK1 is involved in TLR-dependent [263] ...
tripartite motif containing 21
(RING-type E3 ubiquitin transferase)
  • regulation of type I interferon production (GO:0032479) TAS
  • response to type II interferon (GO:0034341) IDA
true Tripartite motif-containing (TRIM) superfamily proteins are critical in a variety of biological processes in innate immunity and are important for eradication of invading pathogens [416,450,561] ...
TXK tyrosine kinase
(Tec family)
  • positive regulation of cytokine production (GO:0001819) ISS
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of type II interferon-mediated signaling pathway (GO:0060335) IDA
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [47] ...
tyrosine kinase 2
(Janus kinase (JakA) family)
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-12-mediated signaling pathway (GO:0035722) IDA
  • interleukin-5-mediated signaling pathway (GO:0038043) NAS
  • interleukin-23-mediated signaling pathway (GO:0038155) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) IDA
  • type I interferon-mediated signaling pathway (GO:0060337) IDA
  • interleukin-10-mediated signaling pathway (GO:0140105) IDA
true TYK2 was the first member of the Janus kinase family to be identified. It associates with the cytoplasmic domain of type I and type II cytokine receptors, where it phosphorylates receptor subunits and facilitates signalling downstream of the receptors for the p40-containing cytokines IL-12 and IL-23 via activation of STAT-dependent transcription factors. It also mediates Type I IFN-driven responses [513] ...
Catalytic Receptors
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
AXL receptor tyrosine kinase
(Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family)
  • positive regulation of cytokine-mediated signaling pathway (GO:0001961) IDA
  • negative regulation of type II interferon production (GO:0032689) IDA
  • cellular response to interferon-alpha (GO:0035457) IDA
true All three TAM family receptor tyrosine kinases are involved in regulating inflammatory responses through a negative feedback loop. Specifically, AXL-Gas6 signalling is reported to induce autophagy in murine macrophages via inhibition of the NLRP3 inflammasome, an effect which reduces hepatic inflammation in a mouse model [200] ...
BAFF receptor
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IEA
true This is a type III membrane bound receptor for B cell activating factor (BAFF). BAFF enhances B cell survival and hence regulates the peripheral B cell population. It is suggested that overproduction of BAFF may enhance the survival of autoreactive B cells, an effect which may contribute in the path ...
B cell maturation antigen
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IEA
true B-cell maturation antigen (BCMA) is a cell surface receptor for B-cell activating factor (BAFF). It interacts with various TRAF family adaptor proteins to modulate cell survival and proliferation, via NF-κB and MAPK8/JNK signal transduction pathways. BCMA is highly plasma cell-selective for malignant plasma cells from multiple myeloma (MM) patients, and is being investigated as a target for therapies to tackle relapsed/refractory MM [218,302] ...
CD30
(Tumour necrosis factor (TNF) receptor family)
  • positive regulation of TRAIL production (GO:0032759) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
true Expressed by activated T and B cells. Interacts with TRAF2 and TRAF5 to elicit downstream signalling events (NF-κB activation). CD30 may protect against autoimmunity by limiting the proliferative potential of autoreactive CD8 effector T cells. CD30 is the target of the approved anti-lymphoma monoclonal antibody drug brentuximab vedotin ...
CD40
(Immune checkpoint catalytic receptors, Tumour necrosis factor (TNF) receptor family)
  • positive regulation of interleukin-4-mediated signaling pathway (GO:1902216) IGI
true CD40 is a stimulatory receptor and a member of the tumor necrosis factor receptor superfamily (TNFRSF). It is expressed on a variety of immune cells, including macrophages, B cells, and dendritic cells (DCs). CD40 plays a key role in the activation of the immune system. Endogenous ligand is CD154 (C ...
CIITA
(NOD-like receptor family)
  • response to type II interferon (GO:0034341) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) IDA
true CIITA is a transcriptional coactivator for the transcription factor RFX5 [483] ...
colony stimulating factor 1 receptor
(Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family)
  • macrophage colony-stimulating factor receptor activity (GO:0005011) IMP
  • cytokine-mediated signaling pathway (GO:0019221) IMP
  • positive regulation of chemokine production (GO:0032722) IMP
  • cellular response to macrophage colony-stimulating factor stimulus (GO:0036006) IMP
  • macrophage colony-stimulating factor signaling pathway (GO:0038145) ISS
  • cellular response to cytokine stimulus (GO:0071345) ISS
true Activation of the CSF1R induces myeloid proliferation, and in the tumour microenvironment this promotes M1 to M2 polarization and accumulation of tumour-associated macrophages (TAMs). The CSF1R is therefore being investigated as an immuno-oncology drug target [3] ...
Cytokine receptor common β subunit
(IL-3 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • interleukin-5-mediated signaling pathway (GO:0038043) IDA
  • interleukin-3-mediated signaling pathway (GO:0038156) IDA
  • granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157) IDA
  • cellular response to interleukin-3 (GO:0036016) IEA
true This a signal transducing protein subunit shared by the functional receptor heterodimers for the cytokines IL-3, IL-5 and GM-CSF, with each receptor having a unique ligand binding alpha subunit.
Cytokine receptor-like factor 2
(IL-2 receptor family)
  • cytokine receptor activity (GO:0004896) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of interleukin-5 production (GO:0032754) IMP
true Cytokine receptor-like factor 2 is the signal transducing subunit of the functional heterodimeric receptor for thymic stromal lymphopoietin (TSLP). Ligand binding is attributed to the interleukin-7 receptor subunit α.
death receptor 3
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor receptor activity (GO:0005031) TAS
true In the absence of any other exogenous signals, activation of DR3 causes proliferation of FoxP3+ regulatory T cells [485] ...
death receptor 6
(Tumour necrosis factor (TNF) receptor family)
  • negative regulation of interleukin-10 production (GO:0032693) ISS
  • negative regulation of interleukin-13 production (GO:0032696) ISS
  • negative regulation of interleukin-5 production (GO:0032714) ISS
  • cellular response to tumor necrosis factor (GO:0071356) IDA
true Expressed predominantly in the thymus, spleen and white blood cells. May play a role in T helper cell activation, inflammation and immune regulation. Signals via the TRADD adaptor protein to the NF-κB and MAPK8/JNK pathways.
DExD/H-box helicase 58
(RIG-I-like receptor family)
  • positive regulation of myeloid dendritic cell cytokine production (GO:0002735) ISS
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) IDA
  • positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) IDA
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) IMP
  • regulation of type III interferon production (GO:0034344) TAS
  • RIG-I signaling pathway (GO:0039529) IDA
  • positive regulation of response to cytokine stimulus (GO:0060760) IMP
true RIG-I is an intracellular sensor that responds to viral nucleic acids and activates downstream signaling, resulting in the induction of the type I interferon response [349] ...
DExH-box helicase 58
(RIG-I-like receptor family)
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) IMP
  • negative regulation of type I interferon production (GO:0032480) IDA
  • positive regulation of type I interferon production (GO:0032481) ISS
  • negative regulation of MDA-5 signaling pathway (GO:0039534) IMP
  • negative regulation of RIG-I signaling pathway (GO:0039536) IDA
  • positive regulation of MDA-5 signaling pathway (GO:1900245) ISS
  • positive regulation of RIG-I signaling pathway (GO:1900246) ISS
true LGP2 binds RNA but does not participate in the signaling pathway that RIG-1 and MDA5 are part of, and is assumed to provide a negative feedback for IFNβ induction by sequestering pathogen-derived RNA.
Eythropoietin receptor
(Prolactin receptor family)
  • erythropoietin receptor activity (GO:0004900) IDA
  • erythropoietin-mediated signaling pathway (GO:0038162) IDA
true A non-hematopoietic EPOR-containing receptor, called the innate repair receptor (IRR) or tissue-protective receptor, down-modulates the damaging effects of the immune response to tissue injury [66] ...
Fas
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor receptor activity (GO:0005031) IDA
true Fas receptor (CD95) is a cell surface protein that belongs to the tumor necrosis factor receptor family, that along with its ligand CD95L (or FasL), generates a death receptor/death ligand system that mediates apoptosis induction to maintain immune homeostasis. This system is also important in the immune elimination of virus-infected cells, cancer cells and autoreactive T cells. Mouse strains with mutations in Fas or FasL develop lymphoproliferative conditions, indicating the importance of these proteins to immune cell homeostasis [526] ...
Fc fragment of IgE receptor Ig
(Fc epsilon receptors)
  • positive regulation of interleukin-4 production (GO:0032753) ISS
  • interleukin-3-mediated signaling pathway (GO:0038156) ISS
true The FCER1G protein is a gamma subunit that is utilised as part of the high affinity IgE receptor (a key complex involved in mediating allergic reactions) and other Fc receptors.
fms related receptor tyrosine kinase 3
(Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family)
  • cytokine receptor activity (GO:0004896) ISS
  • cytokine-mediated signaling pathway (GO:0019221) ISS
  • cellular response to cytokine stimulus (GO:0071345) ISS
true FLT3 is the receptor for the cytokine Flt3 ligand (FLT3LG). Flt3 ligand is a growth factor akin to stem cell factor and colony stimulating factor 1, and is essential for hematopoietic progenitor cell development and expansion of both myeloid and lymphoid lineages. It is one of the growth factor receptors targeted by the chemotherapeutic tyrosine kinase inhibitor sorafenib.
Results from mouse experiments suggest that Flt3 ligand is effective in treating sepsis, by potentiating innate immune functions of dendritic cells and neutrophils and improving T cell function [426] ...
glucocorticoid-induced TNF receptor
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor receptor activity (GO:0005031) TAS
true GITR appears to act as a co-stimulatory immune checkpoint molecule. T cell activation induces GITR expression. GITR inhibits the suppressive activity of Treg cells and promotes survival of Teff cells.
GM-CSF receptor, α subunit
(IL-3 receptor family)
  • growth hormone receptor activity (GO:0004903) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157) IDA
true This is the ligand binding subunit of the functional GM-CSF receptor complex.
Granulocyte colony-stimulating factor receptor
(Prolactin receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
true This nuclear receptor mediates the effects of the cytokine, colony stimulating factor 3 (CSF3). CSF3 regulates the production, differentiation, and function of granulocytes.
herpes virus entry mediator
(Immune checkpoint catalytic receptors, Tumour necrosis factor (TNF) receptor family)
  • positive regulation of cytokine production involved in immune response (GO:0002720) IBA
  • negative regulation of T cell cytokine production (GO:0002725) NAS
  • tumor necrosis factor receptor activity (GO:0005031) TAS
  • regulation of type II interferon production (GO:0032649) NAS
true HSV viral envelope glycoprotein D (gD) binds to this protein and thereby gains entry to the cell. HVEM binds to several TRAFadaptor proteins to mediate intracellular signalling and activation of the immune response.
integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
(Integrins)
  • cellular response to cytokine stimulus (GO:0071345) IEA
true Integrin subunit alpha 4 is the alpha subunit of the α4β1 lymphocyte homing receptor. The cytoplasmic domain of α4 binds tightly to paxillin, a signaling adaptor protein, and this interaction promotes increased cell migration and inhibits cell spreading [203] ...
interferon α/β receptor 1
(Interferon receptor family)
  • type I interferon receptor activity (GO:0004905) IDA
  • cellular response to interferon-alpha (GO:0035457) ISS
  • cellular response to interferon-beta (GO:0035458) IDA
  • type I interferon-mediated signaling pathway (GO:0060337) IDA
true IFNAR1 is a subunit of the functional receptor for type I interferons (NOT interferon γ). Type I interferons (IFN) exhibit an established anti-viral action. However, type I IFN signalling also appears to play a role in impaired resistance to a range of other pathogens (e.g. bacterial infection) [84,393] ...
Interferon α/β receptor 2
(Interferon receptor family)
  • type I interferon receptor activity (GO:0004905) IDA
  • response to interferon-alpha (GO:0035455) IDA
  • response to interferon-beta (GO:0035456) IDA
  • cellular response to interferon-beta (GO:0035458) IDA
  • type I interferon-mediated signaling pathway (GO:0060337) IDA
true A subunit of the functional receptor for various interferons (NOT interferon γ).
Interferon γ receptor 1
(Interferon receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • type II interferon receptor activity (GO:0004906) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • type III interferon-mediated signaling pathway (GO:0038196) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) IDA
true A subunit of the functional receptor for interferon γ.
Interferon γ receptor 2
(Interferon receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • type II interferon receptor activity (GO:0004906) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • type III interferon-mediated signaling pathway (GO:0038196) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) NAS
true A subunit of the functional receptor for interferon γ.
interferon induced with helicase C domain 1
(RIG-I-like receptor family)
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) TAS
  • positive regulation of interferon-alpha production (GO:0032727) IMP
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IMP
  • regulation of type III interferon production (GO:0034344) TAS
  • MDA-5 signaling pathway (GO:0039530) IDA
  • positive regulation of response to cytokine stimulus (GO:0060760) IMP
true MDA5 is an intracellualar RNA sensor. It recognizes longer double-stranded RNA sequences than RIG-1. In autoimmunity, MDA5 has been specifically linked with type I diabetes and anti-MDA5 autoantibodies can be detected in patients with certain connective tissue autoimmune conditions [6,228,365] ...
Interferon-λ receptor subunit 1
(IL-10 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • response to type III interferon (GO:0034342) ISS
  • type III interferon-mediated signaling pathway (GO:0038196) NAS
true Interferon-λ receptor subunit 1 is the ligand binding component of the functional heterodimeric receptor for interferons λ1, λ2 and λ3
Interleukin 10 receptor, α subunit
(IL-10 receptor family)
  • interleukin-10 receptor activity (GO:0004920) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-10-mediated signaling pathway (GO:0140105) IDA
true Interleukin 10 receptor, α subunit is a component of the functional IL-10 receptor heterodimer.
Interleukin 10 receptor, β subunit
(IL-10 receptor family)
  • interleukin-10 receptor activity (GO:0004920) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • type III interferon-mediated signaling pathway (GO:0038196) NAS
  • interleukin-10-mediated signaling pathway (GO:0140105) IDA
true Interleukin 10 receptor, β subunit is a component of the functional receptor heterodimers for interleukins 10 and 22 and for interferons λ1, λ2 and λ3.
Interleukin-11 receptor, α subunit
(IL-6 receptor family)
  • interleukin-11 receptor activity (GO:0004921) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-11-mediated signaling pathway (GO:0038154) IDA
true This is the ligand-binding component of the functional receptor for interleukin 11.
Interleukin-12 receptor, β1 subunit
(IL-12 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • interleukin-12-mediated signaling pathway (GO:0035722) IDA
  • interleukin-23-mediated signaling pathway (GO:0038155) IDA
  • cellular response to type II interferon (GO:0071346) IDA
true This protein is a subunit of both the IL-12 and IL-23 cytokine receptors.
Interleukin-12 receptor, β2 subunit
(IL-12 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • interleukin-12-mediated signaling pathway (GO:0035722) IDA
true This protein is a subunit of the functional receptor heterodimer for the IL-12 cytokine.
Interleukin 13 receptor, α2
(IL-2 receptor family)
  • cytokine receptor activity (GO:0004896) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • transforming growth factor beta1 production (GO:0032905) NAS
  • regulation of transforming growth factor beta1 production (GO:0032908) NAS
  • interleukin-13-mediated signaling pathway (GO:0035772) IDA
true Interleukin 13 receptor, α2 acts as a high affinity decoy receptor for interleukin 13 that sequesters the ligand away from IL13Rα1 and is involved in down-regulating IL-13 responses in vivo. IL13ra2 null mice exhibit enhanced IL-13 responses [592] ...
Interleukin-13 receptor subunit α1
(IL-2 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-4-mediated signaling pathway (GO:0035771) NAS
  • interleukin-13-mediated signaling pathway (GO:0035772) IDA
true Interleukin-13 receptor subunit α1 is a component of the functional receptors that mediate the pro-inflammatory actions of the cytokines IL-4 and IL-13.
Interleukin-15 receptor subunit α
(IL-2 receptor family)
  • cytokine receptor activity (GO:0004896) TAS
  • interleukin-15-mediated signaling pathway (GO:0035723) IMP
  • interleukin-15 receptor activity (GO:0042010) IDA
true This is the ligand binding subunit of the functional IL-15 receptor complex.
Interleukin 17 receptor A
(IL-17 receptor family)
  • interleukin-17 receptor activity (GO:0030368) IDA
  • positive regulation of interleukin-13 production (GO:0032736) NAS
  • positive regulation of interleukin-23 production (GO:0032747) IDA
  • positive regulation of interleukin-5 production (GO:0032754) NAS
  • positive regulation of interleukin-6 production (GO:0032755) IMP
  • interleukin-17A-mediated signaling pathway (GO:0038173) IDA
  • interleukin-17-mediated signaling pathway (GO:0097400) IDA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IDA
  • positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340) IMP
true This protein is a common subunit shared by the heterodimeric receptors for interleukins 17 (A, B , C and F) and 25.
Interleukin 17 receptor B
(IL-17 receptor family)
  • cytokine receptor activity (GO:0004896) NAS
  • interleukin-17 receptor activity (GO:0030368) IBA
  • positive regulation of interleukin-13 production (GO:0032736) NAS
  • positive regulation of interleukin-5 production (GO:0032754) NAS
  • interleukin-17-mediated signaling pathway (GO:0097400) IBA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IBA
true IL17RB is a subunit of the heterodimeric interleukin-25 receptor.
interleukin 17 receptor C
(IL-17 receptor family)
  • interleukin-17 receptor activity (GO:0030368) IDA
  • interleukin-17A-mediated signaling pathway (GO:0038173) IDA
  • interleukin-17-mediated signaling pathway (GO:0097400) IBA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IBA
  • positive regulation of interleukin-6 production (GO:0032755) IEA
true This is a subunit of the heterodimeric interleukin-17 receptor.
Interleukin-17 receptor D
(IL-17 receptor family)
  • interleukin-17 receptor activity (GO:0030368) IBA
  • interleukin-17-mediated signaling pathway (GO:0097400) IBA
true IL17RD acts as an inhibitor of proinflammatory cytokine signaling (by limiting NF-κB translocation to the nucleus) [173] ...
Interleukin 17 receptor E
(IL-17 receptor family)
  • interleukin-17 receptor activity (GO:0030368) IBA
  • interleukin-17-mediated signaling pathway (GO:0097400) IBA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IBA
true This is a component of the heterodimeric interleukin-17C receptor.
Interleukin-18 receptor 1
(Immunoglobulin-like family of IL-1 receptors)
  • positive regulation of type II interferon production (GO:0032729) IDA
  • interleukin-18-mediated signaling pathway (GO:0035655) IDA
  • interleukin-18 receptor activity (GO:0042008) IDA
  • positive regulation of T-helper 1 cell cytokine production (GO:2000556) IDA
  • interleukin-1 receptor activity (GO:0004908) IEA
true Interleukin-18 1 protein (IL18R1) is the ligand binding subunit of the functional IL-18 receptor heterodimer.
Interleukin-1 receptor-like 1
(Immunoglobulin-like family of IL-1 receptors)
  • interleukin-33 receptor activity (GO:0002114) IDA
  • cytokine receptor activity (GO:0004896) TAS
  • interleukin-33-mediated signaling pathway (GO:0038172) IDA
  • interleukin-1 receptor activity (GO:0004908) IEA
  • negative regulation of type II interferon production (GO:0032689) IEA
  • positive regulation of chemokine production (GO:0032722) IEA
  • positive regulation of interleukin-5 production (GO:0032754) IEA
true IL1RL1 (ST2) is the ligand binding subunit of the functional receptor for IL-33. It is mainly expressed on mast cells, eosinophils and other immune cells [178] ...
Interleukin-1 receptor-like 2
(Immunoglobulin-like family of IL-1 receptors)
  • interleukin-1 receptor activity (GO:0004908) TAS
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) NAS
  • interleukin-1, type I, activating receptor activity (GO:0004909) IEA
true Interleukin-1 receptor-like 2 is one of the subunits of the functional receptor for IL-36.

An antibody that mimics IL-36RA's antagonist activity at the IL-36 receptor (MAB92) has been described [177] ...
Interleukin 1 receptor, type I
(Immunoglobulin-like family of IL-1 receptors)
  • interleukin-1 receptor activity (GO:0004908) IDA
  • interleukin-1, type I, activating receptor activity (GO:0004909) TAS
  • positive regulation of type II interferon production (GO:0032729) IDA
  • interleukin-1-mediated signaling pathway (GO:0070498) IDA
  • response to interleukin-1 (GO:0070555) IDA
  • positive regulation of T-helper 1 cell cytokine production (GO:2000556) IDA
  • negative regulation of interleukin-1-mediated signaling pathway (GO:2000660) NAS
true This is one of the subunits of the functional IL-1 receptor type I heterodimer.
Interleukin 1 receptor, type II
(Immunoglobulin-like family of IL-1 receptors)
  • interleukin-1 receptor activity (GO:0004908) IBA
  • negative regulation of interleukin-1 alpha production (GO:0032690) NAS
  • negative regulation of interleukin-1 beta production (GO:0032691) NAS
  • negative regulation of interleukin-1-mediated signaling pathway (GO:2000660) NAS
  • interleukin-1, type II, blocking receptor activity (GO:0004910) IEA
true IL-1R2 acts as a decoy receptor for IL-1β, thus reducing IL-1β binding/activation of IL-1R1. IL-1R2 thereby acts to down-regulate IL-1 responses [188,390] ...
Interleukin 20 receptor, α subunit
(IL-10 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • negative regulation of type II interferon production (GO:0032689) NAS
  • positive regulation of interleukin-13 production (GO:0032736) NAS
  • positive regulation of interleukin-4 production (GO:0032753) NAS
  • cellular response to interleukin-4 (GO:0071353) NAS
true Interleukin 20 receptor, α subunit is a component of the functional receptor heterodimer for interleukin 20.
Interleukin 20 receptor, β subunit
(IL-10 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • negative regulation of type II interferon production (GO:0032689) NAS
  • positive regulation of interleukin-13 production (GO:0032736) NAS
  • positive regulation of interleukin-4 production (GO:0032753) NAS
  • cellular response to interleukin-4 (GO:0071353) NAS
true Interleukin 20 receptor, β subunit is a component of the functional receptor heterodimers for interleukins 19, 20 and 24.
Interleukin 21 receptor
(IL-2 receptor family)
  • interleukin-21 receptor activity (GO:0001532) NAS
  • cytokine receptor activity (GO:0004896) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
true This is the ligand binding subunit of the functional heterodimeric receptor for interleukin 21.
Interleukin 22 receptor, α1 subunit
(IL-10 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • interferon receptor activity (GO:0004904) TAS
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-22 receptor activity (GO:0042018) ISS
  • cellular response to interleukin-4 (GO:0071353) NAS
true IL22RA1 is a subunit in the heterodimeric receptors for interleukins 20 and 24 (which bind to the interleukin-22α1/20β heteromer) and IL-22 (which binds to the interleukin-22α1/10β heteromer).
Interleukin-22 receptor α2
(IL-10 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-22 receptor activity (GO:0042018) IDA
true IL22RA2 (a.k.a. IL-22 binding protein) appears to act as a high affinity, soluble monomeric decoy receptor for IL-22 capable of neutralizeing the potent antimicrobial activity of IL-22 [135,162] ...
Interleukin 23 receptor
(IL-12 receptor family)
  • cytokine receptor activity (GO:0004896) IDA
  • prolactin receptor activity (GO:0004925) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • negative regulation of interleukin-10 production (GO:0032693) IMP
  • positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) IC
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-12 production (GO:0032735) IDA
  • positive regulation of interleukin-17 production (GO:0032740) IC
  • response to type II interferon (GO:0034341) IDA
  • interleukin-23-mediated signaling pathway (GO:0038155) IDA
true This is one of the subunits of the functional IL-23 receptor heterodimer.
Interleukin 27 receptor, alpha
(IL-6 receptor family)
  • positive regulation of interleukin-10 production (GO:0032733) NAS
  • interleukin-27 receptor activity (GO:0045509) IBA
  • interleukin-27-mediated signaling pathway (GO:0070106) NAS
  • negative regulation of interleukin-17 production (GO:0032700) IEA
  • negative regulation of interleukin-6 production (GO:0032715) IEA
  • negative regulation of tumor necrosis factor production (GO:0032720) IEA
true This is the ligand binding subunit of the IL-27 receptor heterodimer, a complex with IL6ST (signal transducing subunit).
Interleukin-2 receptor subunit α
(IL-2 receptor family)
  • interleukin-2 receptor activity (GO:0004911) IDA
  • interleukin-2-mediated signaling pathway (GO:0038110) IDA
true IL2RA is a ligand binding component of the IL-2R complex. This subunit is the molecular target of the approved biologics daclizumab (including daclizumab beta) and basiliximab. Another anti-CD25 mAb, inolimomab, has received orphan drug designation from the EMA, for the treatment of graft-versus-host disease. Phase 3 findings for this drug and indication are reported in [502] ...
Interleukin-2 receptor subunit β
(IL-2 receptor family)
  • interleukin-2 receptor activity (GO:0004911) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • interleukin-15-mediated signaling pathway (GO:0035723) IMP
  • interleukin-2-mediated signaling pathway (GO:0038110) IDA
  • interleukin-15 receptor activity (GO:0042010) IDA
true IL2RB is a ligand binding component of the IL-2R and is required to elevate ligand affinity. It also a component of the IL-15R.
Interleukin-2 receptor subunit γ
(IL-2 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-15-mediated signaling pathway (GO:0035723) IMP
  • interleukin-4-mediated signaling pathway (GO:0035771) NAS
  • interleukin-2-mediated signaling pathway (GO:0038110) IDA
  • interleukin-7-mediated signaling pathway (GO:0038111) IDA
  • interleukin-9-mediated signaling pathway (GO:0038113) IDA
  • interleukin-15 receptor activity (GO:0042010) IDA
true IL2RG is a common signal transducing subunit shared by the receptors for several different cytokines, namely the IL-2 receptor heterotrimer, the IL-4 receptor type I, the IL-7 receptor, the IL-9 receptor, the IL-15 receptor and the IL-21 receptor.
Interleukin-31 receptor, α subunit
(IL-6 receptor family)
  • cytokine receptor activity (GO:0004896) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IDA
true
Interleukin 3 receptor, α subunit
(IL-3 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • interleukin-3 receptor activity (GO:0004912) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-3-mediated signaling pathway (GO:0038156) IDA
true This is the ligand binding subunit of the functional IL-3 receptor complex.
Anti-IL-3RA monoclonal antibodies (mAbs) are being investigated for the treatment of IL-3RA (CD123) positive hematological malignancies [20,279] ...
Interleukin-4 receptor subunit α
(IL-2 receptor family)
  • interleukin-4 receptor activity (GO:0004913) IDA
  • interleukin-4-mediated signaling pathway (GO:0035771) IDA
  • interleukin-13-mediated signaling pathway (GO:0035772) IDA
  • positive regulation of chemokine production (GO:0032722) IEA
true IL4R is the common ligand binding subunit shared by the IL-4 receptors type I (receptor for IL-4) and type II (receptor for IL-4 and IL-13). A gain-of-function mutation in IL4R has been associated with atopy, enhanced B cell isotype switching from mu to epsilon and therefore elevated IgE levels [220] ...
Interleukin 5 receptor, α subunit
(IL-3 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • interleukin-5 receptor activity (GO:0004914) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • interleukin-5-mediated signaling pathway (GO:0038043) IDA
true This is the ligand binding subunit of the functional IL-5 receptor complex.
Interleukin-6 receptor, α subunit
(IL-6 receptor family)
  • cytokine receptor activity (GO:0004896) IDA
  • interleukin-6 receptor activity (GO:0004915) IDA
  • interleukin-11 receptor activity (GO:0004921) IBA
  • vascular endothelial growth factor production (GO:0010573) IDA
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • negative regulation of interleukin-8 production (GO:0032717) NAS
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • response to cytokine (GO:0034097) IDA
  • interleukin-6-mediated signaling pathway (GO:0070102) IDA
  • ciliary neurotrophic factor-mediated signaling pathway (GO:0070120) IMP
true IL6R polymorphisms are associated with asthma risk [163] ...
Interleukin-6 receptor, β subunit
(IL-6 receptor family)
  • negative regulation of cytokine-mediated signaling pathway (GO:0001960) NAS
  • cytokine receptor activity (GO:0004896) IDA
  • ciliary neurotrophic factor receptor activity (GO:0004897) IDA
  • oncostatin-M receptor activity (GO:0004924) IDA
  • positive regulation of vascular endothelial growth factor production (GO:0010575) TAS
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of interleukin-10 production (GO:0032733) NAS
  • response to cytokine (GO:0034097) IDA
  • interleukin-11-mediated signaling pathway (GO:0038154) IDA
  • oncostatin-M-mediated signaling pathway (GO:0038165) IDA
  • interleukin-27 receptor activity (GO:0045509) IMP
  • interleukin-6-mediated signaling pathway (GO:0070102) IDA
  • negative regulation of interleukin-6-mediated signaling pathway (GO:0070104) IDA
  • interleukin-27-mediated signaling pathway (GO:0070106) IMP
  • ciliary neurotrophic factor-mediated signaling pathway (GO:0070120) IDA
  • interleukin-11 receptor activity (GO:0004921) IEA
true This is the common signal transducing subunit shared by members of the IL-6 family of cytokine receptors [466] ...
Interleukin-7 receptor subunit α
(IL-2 receptor family)
  • cytokine receptor activity (GO:0004896) IDA
  • interleukin-7 receptor activity (GO:0004917) IDA
  • interleukin-7-mediated signaling pathway (GO:0038111) IDA
true This is the ligand binding subunit of the functional IL-7 receptor complex.
Effimmune are developing anti-IL7Rα monoclonal antibodies (e.g. OSE-127 [440] ...
Interleukin 9 receptor
(IL-2 receptor family)
  • interleukin-9 receptor activity (GO:0004919) IDA
  • interleukin-9-mediated signaling pathway (GO:0038113) IDA
true The functional IL-9 receptor is a heterodimer of the ligand binding IL-9 receptor subunit and the interleukin 2 receptor γ (IL2RG) subunit. IL2RG is a common signal transducing subunit shared by the receptors for several different cytokines, including those for interleukin-2, -4, -7, and -15. ...
KIT proto-oncogene, receptor tyrosine kinase
(Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family)
  • positive regulation of dendritic cell cytokine production (GO:0002732) ISS
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of mast cell cytokine production (GO:0032765) IDA
  • Kit signaling pathway (GO:0038109) IDA
  • erythropoietin-mediated signaling pathway (GO:0038162) ISS
  • stem cell factor receptor activity (GO:0005020) IEA
true Stem cell factor (SCF) and its receptor KIT (c-KIT) play an essential part in mast cell biology. In addition to CSF/KIT-mediated regulation of mast cell development, proliferation and survival, KIT is also reported to be involved in the adhesion of mast cells to human airway epithelial cells (a homing and adhesion role), suggesting a mechanism that could be targeted for anti-asthmatic potential [192] ...
lymphotoxin β receptor
(Tumour necrosis factor (TNF) receptor family)
  • regulation of type I interferon production (GO:0032479) NAS
true Interaction of the lymphotoxin β receptor (LTBR) with its ligand is required for the development and organization of the secondary lymphoid organs and is involved in chemokine release (reported to induce interleukin 8 gene expression [95] ...
macrophage stimulating 1 receptor
(Type X RTKs: HGF (hepatocyte growth factor) receptor family)
  • macrophage colony-stimulating factor receptor activity (GO:0005011) TAS
true The role of RON in immuno-oncology is reviewed in [3] ...
NLRC3
(NOD-like receptor family)
  • negative regulation of interferon-alpha production (GO:0032687) ISS
  • negative regulation of interferon-beta production (GO:0032688) ISS
  • negative regulation of interleukin-6 production (GO:0032715) IDA
  • negative regulation of tumor necrosis factor production (GO:0032720) IDA
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) ISS
  • negative regulation of NLRP3 inflammasome complex assembly (GO:1900226) IDA
true NLRC3 is an intracellular pattern recognition receptor of the innate immune system. It has been shown to directly interact with and inhibit the type I interferon response of the intracellular DNA sensor STING to cytosolic DNA, cyclic di-GMP (c-di-GMP), and DNA viruses [340,624] ...
NLRC4
(NOD-like receptor family)
  • positive regulation of interleukin-1 beta production (GO:0032731) IGI
true As part of the innate inflammatory response to invading mobile bacteria, NLRC4 (Ipaf) in macrophages induces a pro-inflammatory response upon detection of cytosolic bacterial flagellin. In contrast, extracellular bacterial flagellin is detected by TLR5 [364] ...
NLRC5
(NOD-like receptor family)
  • positive regulation of type II interferon-mediated signaling pathway (GO:0060335) IDA
  • negative regulation of type I interferon-mediated signaling pathway (GO:0060339) IDA
  • positive regulation of type I interferon-mediated signaling pathway (GO:0060340) IDA
true NLRC5 is an intracellular pattern recognition receptor mediating an innate immune response to viral infection [389] ...
NLRP1
(NOD-like receptor family)
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • NLRP1 inflammasome complex assembly (GO:1904784) IDA
true NLRP1 is a cytosolic sensor of bacterial infection and regulator of the resulting innate immune response [93] ...
NLRP10
(NOD-like receptor family)
  • positive regulation of interleukin-1 alpha production (GO:0032730) IMP
  • positive regulation of interleukin-6 production (GO:0032755) IMP
  • positive regulation of interleukin-8 production (GO:0032757) IMP
true NLRP10 is an intracellular pattern recognition receptor (PRR) that has apoptotic and anti-inflammatory functions [238] ...
NLRP3
(NOD-like receptor family)
  • negative regulation of interleukin-1 beta production (GO:0032691) IMP
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-4 production (GO:0032753) ISS
  • NLRP3 inflammasome complex assembly (GO:0044546) IDA
  • positive regulation of T-helper 2 cell cytokine production (GO:2000553) ISS
true NLRP3 is a component of the NLRP3 inflammasome, a protein complex which activates caspase-1, and plays an important role in the regulation of inflammation and apoptosis (pyroptosis). Drug-like NLRP3 inhibitors are under investigation as novel therapeutics for the treatment of autoinflammatory diseases and neuroinflammation, as an alternative to anti-IL-1 therapies such as , and [30,341] ...
NLRP6
(NOD-like receptor family)
  • NLRP6 inflammasome complex assembly (GO:0140739) IDA
  • positive regulation of interleukin-18-mediated signaling pathway (GO:2000494) IDA
true NLRP6 is an intracellular pattern recognition receptor (PRR). It is a member of the NACHT, LRR and PYD domains-containing protein (NALP) subfamily of PRRs. The presence of NALPs in inflammasomes underlies their involvement in regulating proinflammatory caspases (esp. caspase 1) ...
NLRP7
(NOD-like receptor family)
  • negative regulation of interleukin-1 beta production (GO:0032691) IMP
  • cellular response to interleukin-1 (GO:0071347) IEP
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) IMP
true NLRP7 is an intracellular pattern recognition receptor (PRR). It is a member of the NACHT, LRR and PYD domains-containing protein (NALP) subfamily of PRRs. The presence of NALPs in inflammasomes underlies their involvement in regulating proinflammatory caspases (esp. caspase 1) ...
NLRX1
(NOD-like receptor family)
  • negative regulation of RIG-I signaling pathway (GO:0039536) IBA
true NLRX1 is an intracellular pattern recognition receptor that plays a role in host immunity to certain bacterial infections.
nucleotide binding oligomerization domain containing 1
(NOD-like receptor family)
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427) IDA
  • positive regulation of interleukin-1 beta production (GO:0032731) IEA
  • positive regulation of tumor necrosis factor production (GO:0032760) IEA
true NOD1 is an intracellular pattern recognition receptor that initiates an immune response to bacterial molecules containing a D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety.

Mutations in NOD proteins are implicated in various inflammatory diseases associated with aberrant NF-κB activ ...
nucleotide binding oligomerization domain containing 2
(NOD-like receptor family)
  • positive regulation of cytokine production involved in immune response (GO:0002720) IMP
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-10 production (GO:0032733) ISS
  • positive regulation of interleukin-17 production (GO:0032740) IMP
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431) IDA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IDA
  • positive regulation of dendritic cell cytokine production (GO:0002732) IEA
true NOD2 is an intracellular pattern recognition receptor that initiates an immune response to bacterial molecules containing muramyl dipeptide (MDP).

Mutations in NOD proteins are implicated in various inflammatory diseases associated with aberrant NF-κB activity; NF-κB being a major ...
Oncostatin M-specific receptor, β subunit
(IL-6 receptor family)
  • cytokine receptor activity (GO:0004896) IBA
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • response to cytokine (GO:0034097) IDA
  • oncostatin-M-mediated signaling pathway (GO:0038165) IDA
true Oncostatin M-specific receptor, β subunit (OSMR) is a component of two functional heterodimeric receptor complexes:
1. OSMR+ interleukin-6 receptor, β subunit (IL6ST) forms the receptor for oncostatin M
2. OSMR+ interleukin-31 receptor, α subunit forms the recept ...
OX40
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor receptor activity (GO:0005031) IBA
true The OX40/OX40L axis is involved in late T cell costimulatory signalling and both partners are transiently expressed following antigen recognition. This checkpoint is particularly important for sustaining the effector function of Th1 and Th2 T cells. Blocking OX40/OX40L is reported to prevent the development of disease in in vivo autoimmune and inflammatory disease models [581] ...
receptor activator of NF-kappa B
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor receptor activity (GO:0005031) ISS
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IDA
  • response to tumor necrosis factor (GO:0034612) ISS
  • response to interleukin-1 (GO:0070555) ISS
true RANK is the receptor for RANK-ligand (RANKL). It is associated with immune cell function and lymph node development, in addition to bone remodeling and repair, thermal regulation, and mammary gland development. Signals to NF-κB and JNK via TRAF adaptor proteins.
RTP Type C
(Receptor tyrosine phosphatase (RTP) family)
  • negative regulation of cytokine-mediated signaling pathway (GO:0001960) ISS
  • regulation of interleukin-8 production (GO:0032677) IDA
  • negative regulation of interleukin-2 production (GO:0032703) ISS
  • positive regulation of interleukin-2 production (GO:0032743) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • negative regulation of interleukin-4-mediated signaling pathway (GO:1902215) IGI
true CD45 is a high molecular weight cell surface glycoprotein expressed by cells of hematopoietic origin. Alternate transcripts lead to expression of isoforms that differ in their extracellular (ligand binding) domain (potentially facilitating differential and/or cell type specific biological functions [132] ...
single Ig and TIR domain containing
(Immunoglobulin-like family of IL-1 receptors)
  • negative regulation of cytokine-mediated signaling pathway (GO:0001960) ISS
  • negative regulation of chemokine production (GO:0032682) ISS
  • negative regulation of interleukin-1-mediated signaling pathway (GO:2000660) IEA
true IL-1R8 has been identified as a natural killer (NK) cell checkpoint that is involved in regulating NK cells' anti-viral and anti-tumour effector functions [369] ...
TLR1
(Toll-like receptor family)
  • positive regulation of interleukin-6 production (GO:0032755) ISS
  • positive regulation of interleukin-8 production (GO:0032757) IGI
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
true TLR1/2 heterodimers detect and respond to bacterial triacyl lipopeptides [550] ...
TLR2
(Toll-like receptor family)
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of interferon-beta production (GO:0032728) ISS
  • positive regulation of interleukin-12 production (GO:0032735) ISS
  • positive regulation of interleukin-18 production (GO:0032741) ISS
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • cellular response to type II interferon (GO:0071346) IDA
  • positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974) IDA
true TLR1/2 and 2/6 heterodimers detect and initiate an immune response to triacylated and diacylated [384] ...
TLR3
(Toll-like receptor family)
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-12 production (GO:0032735) ISS
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • toll-like receptor 3 signaling pathway (GO:0034138) IDA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IEA
true TLR3 is an endosomal anti-viral receptor [550] ...
TLR4
(Toll-like receptor family)
  • negative regulation of type II interferon production (GO:0032689) ISS
  • negative regulation of interleukin-17 production (GO:0032700) ISS
  • negative regulation of interleukin-23 production (GO:0032707) ISS
  • negative regulation of interleukin-6 production (GO:0032715) ISS
  • negative regulation of tumor necrosis factor production (GO:0032720) ISS
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of interferon-alpha production (GO:0032727) ISS
  • positive regulation of interferon-beta production (GO:0032728) ISS
  • positive regulation of type II interferon production (GO:0032729) ISS
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-1 production (GO:0032732) ISS
  • positive regulation of interleukin-10 production (GO:0032733) ISS
  • positive regulation of interleukin-12 production (GO:0032735) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • cellular response to type II interferon (GO:0071346) IDA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IDA
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) ISS
  • positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974) IDA
  • positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343) IMP
true TLR4 selectively responds to bacterial endotoxin, Gram-negative bacterial lipopolysaccharides (LPS), and lipooligosaccharides (LOS) [54,441] ...
TLR5
(Toll-like receptor family)
  • positive regulation of interleukin-8 production (GO:0032757) IDA
true TLR5 induces a pro-inflammatory response upon detection of extracellular bacterial flagellin from invading mobile bacteria [364] ...
TLR6
(Toll-like receptor family)
  • negative regulation of interleukin-8 production (GO:0032717) IGI
  • positive regulation of interleukin-1 beta production (GO:0032731) ISS
  • positive regulation of interleukin-6 production (GO:0032755) ISS
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) ISS
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) ISS
  • negative regulation of tumor necrosis factor production (GO:0032720) IEA
true TLR6 forms heterodimers with TLR2 to detect a wide range of bacterial lipopeptides (LP) from bacterial cell membranes, and effect an immune response [159] ...
TLR7
(Toll-like receptor family)
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IBA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • toll-like receptor 7 signaling pathway (GO:0034154) IDA
  • toll-like receptor 8 signaling pathway (GO:0034158) IEA
true TLR7 is an endosomal receptor detecting ssRNA [550] ...
TLR8
(Toll-like receptor family)
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IBA
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • toll-like receptor 8 signaling pathway (GO:0034158) IDA
true TLR8 is an endosomal receptor detecting ssRNA [550] ...
TLR9
(Toll-like receptor family)
  • positive regulation of chemokine production (GO:0032722) IDA
  • positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) IDA
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-10 production (GO:0032733) ISS
  • positive regulation of interleukin-12 production (GO:0032735) ISS
  • positive regulation of interleukin-18 production (GO:0032741) ISS
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • toll-like receptor 9 signaling pathway (GO:0034162) IDA
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) ISS
  • positive regulation of toll-like receptor 9 signaling pathway (GO:0034165) IEA
true TLR9 is an endosomal receptor detecting viral and bacterial CpG DNA and genomic DNA from some protozoan species [550] ...
tumor necrosis factor receptor 1
(Tumour necrosis factor (TNF) receptor family)
  • tumor necrosis factor receptor activity (GO:0005031) IDA
  • cytokine-mediated signaling pathway (GO:0019221) ISS
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IMP
true We have included TNFR1 in GtoImmuPdb based on it being a receptor for lymphotoxin-α, a cytotoxic protein performing a variety of important roles in immune system development and regulation [195,394] ...
tumor necrosis factor receptor 2
(Tumour necrosis factor (TNF) receptor family)
  • regulation of cytokine production involved in immune response (GO:0002718) ISS
  • regulation of T cell cytokine production (GO:0002724) ISS
  • tumor necrosis factor receptor activity (GO:0005031) IBA
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) TAS
true TNFR2 is a receptor for lymphotoxin-α, and the membrane form of tumour necrosis factor (TNF). It plays a variety of important roles in immune system development and regulation [195,394] ...
Transporters
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
L-type amino acid transporter 1
(SLC7 family)
  • positive regulation of cytokine production involved in immune response (GO:0002720) TAS
  • positive regulation of type II interferon production (GO:0032729) IMP
  • positive regulation of interleukin-17 production (GO:0032740) IMP
  • positive regulation of interleukin-4 production (GO:0032753) IMP
true LAT1 has been identified as being a key transporter of the essential amino acids [214] ...
NRAMP1
(SLC11 family of proton-coupled metal ion transporters)
  • negative regulation of cytokine production (GO:0001818) ISS
  • positive regulation of cytokine production (GO:0001819) ISS
  • positive regulation of type II interferon production (GO:0032729) ISS
  • response to type II interferon (GO:0034341) ISS
true NRAMP1 / SLC11A1 appears to be involved in macrophage antimicrobial action against intracellular pathogens, and although its precise mechanism is not fully resolved, evidence indicates its involvement in the activation of phagocytes and synthesis of proinflammatory cytokines. Polymorphisms in the human SLC11A1 gene have been associated with susceptibility to several infections [67,505,508] ...
Peptide transporter 3
(SLC15 family of peptide transporters)
  • positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434) ISS
true SLC15A3 and SLC15A4 are preferentially expressed by cells within the lymphatic system, including dendritic cells. Expression of these two genes is upregulated in response to TLR stimulation [383,506] ...
Peptide transporter 4
(SLC15 family of peptide transporters)
  • positive regulation of toll-like receptor 7 signaling pathway (GO:0034157) IDA
  • positive regulation of toll-like receptor 8 signaling pathway (GO:0034161) IDA
  • positive regulation of toll-like receptor 9 signaling pathway (GO:0034165) IDA
  • regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070424) ISS
  • positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430) ISS
  • positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434) ISS
true SLC15A4 is an oligopeptide transporter that is expressed in early endosomes. It is critical for signalling via certain pattern recognition receptors (e.g. Toll-like receptors 7-9 and NOD receptors) in immune cell subsets [295] ...
Other Protein Targets
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
absent in melanoma 2
(Absent in melanoma (AIM)-like receptors (ALRs))
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IDA
  • cellular response to interferon-beta (GO:0035458) IBA
true AIM2 primarily senses cytosolic DNA and initiates formation of an inflammasome to drive IL-1β cleavage and secretion.
advanced glycosylation end-product specific receptor
(Immunoglobulin like domain containing proteins)
  • negative regulation of interleukin-10 production (GO:0032693) IDA
  • positive regulation of chemokine production (GO:0032722) ISS
  • positive regulation of interleukin-1 beta production (GO:0032731) ISS
  • positive regulation of interleukin-12 production (GO:0032735) IMP
  • positive regulation of interleukin-6 production (GO:0032755) ISS
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
  • positive regulation of endothelin production (GO:1904472) ISS
true RAGE is a single chain, membrane bound immunoglobulin type protein [388,480,601] ...
B7-H3 (CD276)
(Other immune checkpoint proteins, CD molecules)
  • regulation of cytokine production (GO:0001817) IBA
  • positive regulation of type II interferon production (GO:0032729) IDA
true B7-H3 is an immunoregulatory receptor involved in T cell activation and IFN-γ production [100,147] ...
baculoviral IAP repeat containing 2
(Inhibitors of apoptosis (IAP) protein family)
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) TAS
  • regulation of RIG-I signaling pathway (GO:0039535) TAS
  • regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070424) TAS
true Cellular inhibitors of apoptosis proteins BIRC2 and BIRC3 are required for efficient caspase-1 activation by the inflammasome [287] ...
baculoviral IAP repeat containing 3
(Inhibitors of apoptosis (IAP) protein family)
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) TAS
  • regulation of RIG-I signaling pathway (GO:0039535) TAS
  • regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070424) TAS
true Cellular inhibitor of apoptosis proteins (cIAPs) suppress apoptosis thereby promoting cell survival, and participate in the immune response (e.g. negative regulation of the necrosome, inflammasome and ripoptosome. In asthma, cIAPs extend the survival of neutrophils, macrophages and eosinophils, prolonging the inflammation. The minor alleles of single nucleotide polymorphisms in BIRC3 are shown to correlate with reduced numbers of circulating eosinophils and neutrophils, suggesting a protective effect against the development of asthma[465] ...
BCL2 apoptosis regulator
(B-cell lymphoma 2 (Bcl-2) protein family)
  • response to cytokine (GO:0034097) IDA
true The role of Bcl-2 family members in immunity and disease is reviewed in [148] ...
Bcl-2-like 1
(B-cell lymphoma 2 (Bcl-2) protein family)
  • response to cytokine (GO:0034097) IDA
true The role of Bcl-2 family members in immunity and disease is reviewed in [5] ...
BCL6 transcription repressor
(BTB (POZ) domain containing TFs)
  • regulation of cytokine production (GO:0001817) IBA
true BCL6/corepressor complexes are important for the formation of germinal centers and differentiation and proliferation of lymphocytes. Oncogenic mutations in BCL6 lead to the development of diffuse large B-cell lymphoma cells from germinal center B cells. Disruption of BCL6/corepressor complex formation by pharmacological inhibitors has therefore been identified as a novel drug mechanism with potential for the treatment of autoimmune diseases and cancer [83,90] ...
butyrophilin like 3
(Butyrophilin and butyrophilin-like proteins)
  • regulation of cytokine production (GO:0001817) IBA
true BTNL3 and BTNL8 are two proteins expressed on the surface of human gut epithelial cells that are involved in shaping the constitution of gut resident dendritic γδ T cells [142] ...
butyrophilin like 8
(Butyrophilin and butyrophilin-like proteins)
  • regulation of cytokine production (GO:0001817) IBA
true BTNL3 and BTNL8 are two proteins expressed on the surface of human gut epithelial cells that are involved in shaping the constitution of gut resident dendritic γδ T cells [142] ...
butyrophilin subfamily 3 member A1
(Butyrophilin and butyrophilin-like proteins)
  • regulation of cytokine production (GO:0001817) IBA
  • positive regulation of cytokine production (GO:0001819) IDA
  • positive regulation of type II interferon production (GO:0032729) IMP
true Vγ2Vδ2 (a.k.a. Vγ9Vδ2) T cells bridge the gap between innate and adaptive immunity and play roles in microbial immunity and tumour immunity [373] ...
CD14 molecule
(CD molecules)
  • positive regulation of cytokine production (GO:0001819) IBA
  • positive regulation of type II interferon production (GO:0032729) ISS
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • positive regulation of type I interferon production (GO:0032481) IEA
true Because of its key role in amplifying the immune response, CD14 was targeted for pharmacological modulation. Implicit Bioscience developed a first-in-class anti-CD14 monoclonal antbody (atibuclimab; IC14) as a clinical lead [510,560] ...
CD2
(CD molecules)
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
true CD2 is a cell surface glycoprotein expressed on most human T cells and natural killer (NK) cells [603] ...
CD226 molecule
(CD molecules)
  • positive regulation of natural killer cell cytokine production (GO:0002729) IEA
true CD226 is an immunoglobulin-like adhesion molecule. It is a co-stimulatory partner for the PVR cell adhesion molecule (CD155). CD226 is expressed on T cells, NK cells and platelets. The CD155-CD226/TIGIT axis forms an immune checkpoint that has emerged as a target for tumour immunotherapy (to combat tumour immunoevasion) [419,594,631] ...
CD24 molecule
(CD molecules)
  • regulation of cytokine-mediated signaling pathway (GO:0001959) ISS
  • negative regulation of transforming growth factor beta3 production (GO:0032913) IMP
  • negative regulation of interleukin-6 production (GO:0032715) IEA
  • negative regulation of tumor necrosis factor production (GO:0032720) IEA
  • negative regulation of monocyte chemotactic protein-1 production (GO:0071638) IEA
true CD24 is a small GPI-anchored sialoglycoprotein that is expressed by immune cells. It is involved in B cell and T cell functions. CD24 binds to SIGLEC10 in an interaction that selectively suppresses the immune response to danger-associated molecular patterns (DAMPs). This latter action is being explo ...
CD28
(Other immune checkpoint proteins, CD molecules)
  • positive regulation of cytokine production (GO:0001819) TAS
  • positive regulation of interleukin-10 production (GO:0032733) IDA
  • positive regulation of interleukin-2 production (GO:0032743) IDA
  • positive regulation of interleukin-4 production (GO:0032753) IDA
true CD28 is expressed on the surface of T cells and is required for the co-stimulatory signal essential for the activation, proliferation and survival of T cells, and Th2 cell development. CD28 acts in concert with the T cell receptor to stimulate cytokine release (promotes IL-2 production). CD28 binds the the B7 proteins CD80 and CD86 on the surface of antigen presenting cells to effect a co-stimulatory signal to T cells. In contrast, CTLA-4 delivers a co-inhibitory signal via CD80/CD86 [10] ...
CD33
(Other immune checkpoint proteins, CD33-related SIGLECs, CD molecules)
  • negative regulation of interleukin-1 beta production (GO:0032691) IMP
  • negative regulation of interleukin-8 production (GO:0032717) IMP
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
true CD33 (SIGLEC3) is a myeloid cell I-type (Ig-type) lectin that binds glycans containing sialic acids [182] ...
CD36 molecule (CD36 blood group)
(CD molecules)
  • positive regulation of interleukin-1 beta production (GO:0032731) ISS
  • positive regulation of NLRP3 inflammasome complex assembly (GO:1900227) ISS
true CD36 expressed by macrophages plays a key role in the recognition and phagocytosis (scavenging) of multiple ligands that are recognised either as damage-associated molecular patterns (DAMPs) released by apoptotic cells, or as potentially dangerous pathogen-associated ligands. CD36 associates with specific Toll-like receptor (TLR) DAMP-detecting heterodimers when bound by certain ligands, and following internalisation of the ligand/CD36/TLR clusters, inflammatory responses (e.g. NF-κB-dependent production of CXCL1, CXCL2, CCL9 and CCL5, NLRP3 inflammasome-mediated IL-1B production, and NF-κB-dependent production of TNF in reponse to microbial diacylated lipopeptide) are triggered. Pharmacological modulation of CD36/TLR signalling is being explored as a strategy to suppress macrophage-driven inflammation [134,547,623] ...
CD38
(CD molecules, Abscisic acid receptor complex)
  • response to interleukin-1 (GO:0070555) IEA
true CD38 is a type II transmembrane glycoprotein, that is widely expressed on immune cells and is involved in cell adhesion and signal transduction. Its extracellular domain acts as an ectoenzyme, catalyzing the conversion of nicotinamide adenine dinucleotide (NAD+) into nicotinamide, adenosine diphosphate-ribose (ADPR), and cyclic ADPR. Expression of CD38 is tightly regulated during B-cell development and maturation [199] ...
CD4
(CD molecules)
  • positive regulation of interleukin-2 production (GO:0032743) NAS
  • interleukin-15-mediated signaling pathway (GO:0035723) IDA
  • interleukin-16 receptor activity (GO:0042012) IDA
  • cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011) IDA
true CD4 is being targeted for clinical utility in inflammatory diseases like rheumatoid arthritis (RA), neoplasms derived from T helper cells (T cell lymphomas and related malignancies), and for anti-HIV potential. Depending on the design of CD4 targeting antibodies, they can produce immunosuppressive effects via activation of Tregs and induction of tolerance, block HIV binding to CD4 to prevent HIV infection, or induce depletion of CD4+ T cells by apoptosis, ADCC, or CDC [275,562] ...
CD47
(CD molecules)
  • regulation of type II interferon production (GO:0032649) IMP
  • regulation of interleukin-10 production (GO:0032653) IMP
  • regulation of interleukin-12 production (GO:0032655) IMP
  • regulation of interleukin-6 production (GO:0032675) IMP
  • regulation of tumor necrosis factor production (GO:0032680) IMP
  • cellular response to type II interferon (GO:0071346) ISS
  • cellular response to interleukin-1 (GO:0071347) ISS
  • cellular response to interleukin-12 (GO:0071349) IMP
true CD47 belongs to the immunoglobulin superfamily and is reported to bind membrane integrins and the ligands thrombospondin 1 (THBS1) and signal-regulatory protein alpha (SIRPα). It is a ubiquitously expressed membrane protein that is a 'marker of self', and it is involved in self tolerance. Binding to SIRPα produces an anti-phagocytic signal.

The CD47/THBS1 axis has been implicated in wound healing, and in the pathological progression of immune thrombocytopenia (ITP) [610] ...
CD55 molecule (Cromer blood group)
(CD molecules)
  • positive regulation of T cell cytokine production (GO:0002726) IDA
true CD55 is a glycoprotein that is crucial for regulation of the complement cascade. Complement proteins are degraded when bound by CD55. Mutations in the CD55 gene drive excessive complement pathway activation that is observed in patients with the ultra-rare and life-threatening hereditary immune disea ...
CD6
(CD molecules)
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IDA
true CD6 is a co-stimulatory molecule, predominantly expressed on lymphocytes and associated with autoimmune responses. CD6 interacts with activated leucocyte-cell adhesion molecule (ALCAM/CD166), found on antigen presenting cells. This interaction induces the production of proinflammatory cytokines [380] ...
CD74
(CD molecules)
  • positive regulation of cytokine-mediated signaling pathway (GO:0001961) IMP
  • cytokine receptor activity (GO:0004896) IDA
  • positive regulation of chemokine production (GO:0032722) IMP
  • positive regulation of interleukin-6 production (GO:0032755) IMP
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • response to type II interferon (GO:0034341) IDA
  • positive regulation of macrophage cytokine production (GO:0060907) ISS
  • positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343) ISS
  • positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448) IMP
  • macrophage migration inhibitory factor signaling pathway (GO:0035691) IEA
true CD74 is a type II transmembrane glycoprotein which associates with the MHC class II α and β chains and directs the transport of class II molecules to lysosomal and endosomal compartments [118] ...
CD80
(Other immune checkpoint proteins, CD molecules)
  • positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) NAS
  • positive regulation of interleukin-2 production (GO:0032743) NAS
true CD80 (B7-1) is expressed on dendritic cells and activated B cells and monocytes. It is required to provide a costimulatory signal necessary for T cell activation and survival. CD80 works in concert with CD86 to prime T cells. CD80 binds CD28 and CTLA-4 on T cells. It is the interaction with CTLA-4 t ...
CD86
(Other immune checkpoint proteins, CD molecules)
  • positive regulation of interleukin-2 production (GO:0032743) NAS
  • positive regulation of interleukin-4 production (GO:0032753) NAS
  • positive regulation of lymphotoxin A production (GO:0032761) NAS
true CD86 (B7-2) is a type I membrane immunoglobulin. It is expressed on antigen-presenting cells and in association with CD80 provides the costimulatory signal necessary for T cell activation and survival. CD86 interacts with CD28 or CTLA-4 on T cells. It is the interaction with CTLA-4 that is targeted ...
chitinase 3 like 1
(Chitinase-like proteins)
  • positive regulation of interleukin-8 production (GO:0032757) ISS
  • transforming growth factor beta1 production (GO:0032905) NAS
  • response to tumor necrosis factor (GO:0034612) IEP
  • response to interleukin-1 (GO:0070555) IEP
  • response to interleukin-6 (GO:0070741) IEP
  • cellular response to tumor necrosis factor (GO:0071356) ISS
true CHI3L1 is recognised as a proinflammatory mediator in the development and progression of Th2 inflammation, such as in allergic reactions [79] ...
C-type lectin domain family 12 member A
(C-type lectin-like receptors (CLRs))
  • positive regulation of type I interferon production (GO:0032481) ISS
true The CLEC12A protein is a negative regulator of granulocyte and monocyte function [205,344] ...
C-type lectin domain family 4 member A
(C-type lectin-like receptors (CLRs))
  • negative regulation of cytokine production (GO:0001818) IDA
  • negative regulation of tumor necrosis factor production (GO:0032720) IDA
true CLEC4A is an pattern recognition receptor and immunoreceptor that functions in cell adhesion, cell-cell signalling, glycoprotein turnover, and plays roles in inflammation and the immune response. It contains a immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain.
C-type lectin domain family 4 member E
(C-type lectin-like receptors (CLRs))
  • positive regulation of cytokine production (GO:0001819) IEA
true Mincle is an FcRγ-associated membrane receptor involved in initiating the innate immune response upon recognition of endogenous and exogenous ligands including Sin3A-associated protein (SAP130), α-mannan on fungal cell walls and mycobacterial cord factor (trehalose-6,6′-dimycolate (TDM)) [70] ...
C-type lectin domain family 6 member A
(C-type lectin-like receptors (CLRs))
  • positive regulation of cytokine production (GO:0001819) ISS
true Dectin-2 is involved in initiating the innate immune response upon recognition of high mannose structures on fungal cell walls. It associates with the ITAM-containing FcRβ adaptor and signals through the Syk, PKCδ, and CARD9-Bcl10-MALT1 pathways to promote cytokine production in response ...
C-type lectin domain family 7 member A
(C-type lectin-like receptors (CLRs))
  • positive regulation of cytokine production involved in immune response (GO:0002720) IBA
  • positive regulation of dendritic cell cytokine production (GO:0002732) ISS
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-10 production (GO:0032733) IDA
  • positive regulation of interleukin-12 production (GO:0032735) IDA
  • positive regulation of interleukin-2 production (GO:0032743) IDA
  • positive regulation of interleukin-23 production (GO:0032747) ISS
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
  • positive regulation of monocyte chemotactic protein-1 production (GO:0071639) IMP
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IDA
true Dectin-1 is a pattern recognition receptor involved in initiating the innate immune response upon recognition of various β(1,3)-linked and β(1,6)-linked glucans from fungi and plants. It mediates phagocytosis and the production of inflammatory mediators [69] ...
Fc alpha receptor
(Immunoglobulin like domain containing proteins, CD molecules)
  • cellular response to interferon-alpha (GO:0035457) IDA
  • cellular response to type II interferon (GO:0071346) IDA
  • cellular response to interleukin-6 (GO:0071354) IDA
  • cellular response to tumor necrosis factor (GO:0071356) IDA
  • cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011) IDA
true FcαRI is the cognate receptor for immunoglobulin A (IgA). In humans, IgA is predominantly expressed in the intestine, where it is important for maintaining mucosal homeostasis. IgA serves as a first-line defence to protect the gut epithelium from pathogens and enteric toxins [343,418] ...
Fc gamma receptor IIIa
(CD molecules, Immunoglobulin like domain containing proteins)
  • positive regulation of tumor necrosis factor production (GO:0032760) IDA
true The FCGR3A gene is expressed by natural killer (NK) cells. The protein product (CD16A or FcγRIIIa) is an integral peptide-tethered membrane glycoprotein. FcγRIIIa is a low-affinity receptor for IgG Fc and is involved in removing antigen-antibody complexes from the circulation and antibody-dependent responses.

FcγRIIIa is being exploited for drug development, specifically as a NK cell-engager to mediate NK effector cell killing of cancer cells. For example, Affimed have developed , a tetravalent bispecific Fv peptide construct that simultaneously engages FcγRIIIa and CD30 on CD30-expressing malignant cells such as Hodgkin lymphoma cells, and AFM24 another tetravalent bispecific construct that targets epidermal growth factor receptor (EGFR) and FcγRIIIa to engage NK cells to destroy otherwise hard to treat EGFR-driven cancers.

COVID-19: Analysis of blood from controls and COVID-19 patients was used to show that FcγRIIIa mediates phagocytosis of antibody-opsonised SARS-CoV-2 particles by human monocytes (and macrophages) [256] ...
gasdermin D
(Gasdermins (GSDM))
  • positive regulation of interleukin-1 beta production (GO:0032731) ISS
true Gasdermin D is a component of the NLRP3 inflammasome/caspase-1/GSDMD signaling pathway and it is required for pyroptosis.
interferon gamma inducible protein 16
(Absent in melanoma (AIM)-like receptors (ALRs))
  • positive regulation of cytokine production (GO:0001819) TAS
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • cellular response to interferon-beta (GO:0035458) IBA
  • negative regulation of AIM2 inflammasome complex assembly (GO:0140972) IDA
true IFI16 is a sensor for cytosolic DNA which induces type I interferon production via activation of the IRF3/NFκB pathway.
leukocyte immunoglobulin like receptor A4
(CD molecules)
  • cytokine-mediated signaling pathway (GO:0019221) IBA
  • negative regulation of interferon-alpha production (GO:0032687) IMP
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
  • negative regulation of toll-like receptor 7 signaling pathway (GO:0034156) IMP
  • negative regulation of toll-like receptor 9 signaling pathway (GO:0034164) IMP
true LILRA4 (CD85g) is a member of the activating leukocyte immunoglobulin like receptor (LILRA) family (HGNC family 1181). It is involved in activation of eosinophils and homeostatic regulation of the innate immunity of plasmacytoid dendritic cells (pDCs) [82] ...
leukocyte immunoglobulin like receptor B1
(CD molecules, Other immune checkpoint proteins)
  • negative regulation of cytokine production involved in immune response (GO:0002719) IDA
  • negative regulation of interferon-beta production (GO:0032688) IDA
  • negative regulation of type II interferon production (GO:0032689) IDA
  • negative regulation of interleukin-10 production (GO:0032693) IDA
  • negative regulation of interleukin-12 production (GO:0032695) IDA
  • negative regulation of tumor necrosis factor production (GO:0032720) IDA
  • positive regulation of type II interferon production (GO:0032729) IDA
  • positive regulation of macrophage cytokine production (GO:0060907) IDA
  • negative regulation of transforming growth factor beta production (GO:0071635) IDA
  • interleukin-10-mediated signaling pathway (GO:0140105) IBA
true LILRB1 (CD85j) is a member of the inhibitory leukocyte immunoglobulin like receptor (LILRB) family (HGNC family 1182). It acts as an inhibitory immune checkpoint for B cell function. Ligands identified for LILRB include native MHC class I proteins, some HLA molecules, pathogen-derived ligands (e.g. from CMV, Dengue virus and some bacteria) and host immunomodulatory proteins such as S100 calcium binding protein A9 (S100A9; P06702; which also binds TLR4 and RAGE) [72] ...
lymphocyte antigen 96
(Lymphocyte antigens)
  • positive regulation of tumor necrosis factor production (GO:0032760) ISS
true LY96 (MD2) is a binding partner of Toll-like receptor 4 (TLR4), required to initiate an innate immune response to bacterial lipopolysaccharide (LPS). The signaling complex also contains CD14 co-receptor [273] ...
myeloid cell nuclear differentiation antigen
(Absent in melanoma (AIM)-like receptors (ALRs))
  • cellular response to interferon-beta (GO:0035458) IBA
true MNDA can be detected exclusively in nuclei of hematopoietic cells of the monocyte lineage. Expression is induced by interferon α [65] ...
NFKB inhibitor zeta
(Inhibitors of NF-kappaB (IκB) family proteins)
  • cytokine-mediated signaling pathway (GO:0019221) IEA
  • response to interleukin-12 (GO:0070671) IEA
  • response to interleukin-18 (GO:0070673) IEA
  • cellular response to interleukin-17 (GO:0097398) IEA
true IκBζ is a key component of the immune response that regulates the transcription of a set of inflamatory genes through its association with the p50 or p52 subunits of NF-κB. IκBζ acts as an inhibitor of primary NF-κB response genes, but may also act as a coactivator of the expression of secondary response genes (through association with the NF-κB p50 subunit). IκBζ is in fact the product of a primary NF-κB reponse gene, being rapidly upregulated by various inflammatory stimuli. Pro-inflammatory gene products that are regulated by IκBζ include CCL2, IL-6, IL12p40, IL-17, IFNγ, and GM-CSF [253,265] ...
notch receptor 1
(Notch receptors)
  • interleukin-17-mediated signaling pathway (GO:0097400) IEA
true NOTCH1 and its ligand Delta-like 4 (DLL4) play a dominant role in mediating the effects of Notch signaling in T cells during Graft-versus-host disease (GvHD). Anti-NOTCH1 or anti-DLL4 antibodies controlled GvHD [544] ...
nuclear factor, erythroid 2 like 2
(Basic leucine zipper domain TFs)
  • cellular response to tumor necrosis factor (GO:0071356) IMP
true NRF2 is included in GToImmuPdb as mutations in this gene have been reported in patients with IMDDHH, an inherited disease in which some of the symptoms arise from defective immune system function [234] ...
pyrin and HIN domain family member 1
(Absent in melanoma (AIM)-like receptors (ALRs))
  • cellular response to interferon-alpha (GO:0035457) IMP
  • cellular response to interferon-beta (GO:0035458) IBA
true PYHIN1 participates in the innate immune response to microbial DNA [144] ...
regulator of G-protein signaling 10
(R12 family)
T cells, macrophages, osteoclasts and microglia.
true Expression of RGS10 in microglia suppresses pro-inflammatory signalling. RGS10 expression is silenced following microglial activation (by IFNγ for example) and this amplifies inflammatory responses in the central nervous system. Small molecules that can reverse IFNγ-mediated RGS10 silencing have been reported [528] ...
RELA proto-oncogene, NF-kB subunit
(NF-kappa B TF proteins)
  • positive regulation of vascular endothelial growth factor production (GO:0010575) IMP
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of interleukin-1 beta production (GO:0032731) IDA
  • positive regulation of interleukin-6 production (GO:0032755) IDA
  • positive regulation of interleukin-8 production (GO:0032757) IDA
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IDA
  • response to cytokine (GO:0034097) IBA
  • prolactin signaling pathway (GO:0038161) IMP
  • nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431) IDA
  • interleukin-1-mediated signaling pathway (GO:0070498) IGI
  • response to interleukin-1 (GO:0070555) IGI
  • cellular response to interleukin-1 (GO:0071347) IDA
  • cellular response to interleukin-6 (GO:0071354) IMP
  • cellular response to tumor necrosis factor (GO:0071356) IDA
  • cGAS/STING signaling pathway (GO:0140896) TAS
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) IDA
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) TAS
true
selectin P (CD62)
(CD molecules)
  • response to cytokine (GO:0034097) IBA
true Leukocytes use P-selectin/selectin P ligand binding to facilitate tethering and rolling on endothelial surfaces [358] ...
signal transducer and activator of transcription 1
(STAT transcription factors)
  • positive regulation of interferon-alpha production (GO:0032727) IDA
  • tumor necrosis factor-mediated signaling pathway (GO:0033209) IDA
  • response to type II interferon (GO:0034341) IDA
  • response to interferon-beta (GO:0035456) IMP
  • cellular response to interferon-beta (GO:0035458) IDA
  • interleukin-7-mediated signaling pathway (GO:0038111) IDA
  • interleukin-9-mediated signaling pathway (GO:0038113) IDA
  • type II interferon-mediated signaling pathway (GO:0060333) IDA
  • type I interferon-mediated signaling pathway (GO:0060337) IDA
  • interleukin-27-mediated signaling pathway (GO:0070106) IDA
  • cellular response to type II interferon (GO:0071346) IDA
true STAT1 is involved in lipid metabolism and progression of inflammatory responses.
signal transducer and activator of transcription 3
(STAT transcription factors)
  • positive regulation of vascular endothelial growth factor production (GO:0010575) IMP
  • cytokine-mediated signaling pathway (GO:0019221) IDA
  • positive regulation of interleukin-1 beta production (GO:0032731) IGI
  • positive regulation of interleukin-10 production (GO:0032733) IGI
  • positive regulation of interleukin-6 production (GO:0032755) ISS
  • positive regulation of interleukin-8 production (GO:0032757) IGI
  • positive regulation of tumor necrosis factor production (GO:0032760) IGI
  • leptin-mediated signaling pathway (GO:0033210) IDA
  • interleukin-15-mediated signaling pathway (GO:0035723) IDA
  • interleukin-2-mediated signaling pathway (GO:0038110) IDA
  • interleukin-9-mediated signaling pathway (GO:0038113) IDA
  • interleukin-11-mediated signaling pathway (GO:0038154) IDA
  • interleukin-23-mediated signaling pathway (GO:0038155) IDA
  • oncostatin-M-mediated signaling pathway (GO:0038165) IDA
  • interleukin-6-mediated signaling pathway (GO:0070102) IDA
  • ciliary neurotrophic factor-mediated signaling pathway (GO:0070120) IDA
  • interleukin-10-mediated signaling pathway (GO:0140105) IDA
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) ISS
  • positive regulation of cytokine production involved in inflammatory response (GO:1900017) IGI
true STAT3 regulates the expression of a variety of genes in response to cytokines and growth factors (e.g. IFNs, EGF, IL-5, IL-6, HGF, LIF and BMP2) and plays important roles in several cellular processes, including cell growth and apoptosis. STAT3 is a crucial component of the JAK/STAT signalling pathway that is implicated in cancer and inflammation. STAT3 is frequently activated in cancers, where it downmodulates intrinsic immune surveillance of tumour cells. Phosphorylated (activated) STAT3 (pSTAT3) is a marker of poor cancer prognosis [613,617] ...
signal transducer and activator of transcription 6
(STAT transcription factors)
  • cytokine-mediated signaling pathway (GO:0019221) IMP
  • interleukin-4-mediated signaling pathway (GO:0035771) IDA
true STAT6 plays a central role in exerting IL-4 mediated biological responses. The prosurvival activity of the Th2 cytokine IL-4 is mediated by STAT6-dependent transcription of the anti-apoptotic protein B-cell lymphoma-extra large (Bcl-XL). This mechanism explains the resistance to apoptosis that is observed epithelial tumours which produce IL-4 [538] ...
SIRPA (CD172a)
(CD molecules, Signal regulatory proteins)
  • regulation of type II interferon production (GO:0032649) IMP
  • regulation of interleukin-1 beta production (GO:0032651) ISS
  • regulation of interleukin-6 production (GO:0032675) ISS
  • regulation of tumor necrosis factor production (GO:0032680) IGI
  • negative regulation of interferon-beta production (GO:0032688) ISS
  • negative regulation of interleukin-6 production (GO:0032715) ISS
  • negative regulation of tumor necrosis factor production (GO:0032720) ISS
  • cellular response to type II interferon (GO:0071346) ISS
  • cellular response to interleukin-1 (GO:0071347) ISS
  • cellular response to interleukin-12 (GO:0071349) IMP
  • negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641) ISS
  • negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650) ISS
  • negative regulation of cytokine production involved in inflammatory response (GO:1900016) ISS
true SIRPα is an important inhibitory immune response regulator. In interaction with CD47, SIRPα controls an inhibitory innate immune checkpoint that provides an anti-phagocytic (do not eat) signal. SIRPα is predominantly expressed by macrophages. Laboratory work has established that SIRPα is expressed by a subset of intestinal dendritic cells (integrin CD103+ DCs) that are critical for maintaining intestinal (mucosal) immune system homeostasis. This subset of CD103+SIRPα+ DCs selectively activates Th17 cells and type 3 innate lymphoid cells (ILC3) [251,578] ...
stimulator of interferon response cGAMP interactor 1
(Other pattern recognition receptors)
  • positive regulation of cytokine production (GO:0001819) IDA
  • cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) IDA
  • positive regulation of type I interferon production (GO:0032481) IDA
  • positive regulation of interferon-beta production (GO:0032728) IDA
  • positive regulation of type I interferon-mediated signaling pathway (GO:0060340) IDA
  • cGAS/STING signaling pathway (GO:0140896) IDA
true STING functions as a major regulator of the innate immune response to viral and bacterial infections [329] ...
TIGIT
(Other immune checkpoint proteins, Immunoglobulin like domain containing proteins)
  • negative regulation of interleukin-12 production (GO:0032695) IMP
  • positive regulation of interleukin-10 production (GO:0032733) IMP
true TIGIT is now considered as an alternate inhibitory immune checkpoint protein which may have potential immunotherapeutic potential, particularly in conditions refractory to more established PD-1 checkpoint inhibition. Given its presence on T cells and NK cells, TIGIT offers an intervention point for targeting both the adaptive and innate arms of the immune system. Clinical development of anti-TIGIT monoclonal antibodies is in preliminary stages. Combination therapies with existing immune checkpoint inhibitors are considered particularly promising. MTIG7192A (NCT02794571; ± anti-PD-L1 atezolizumab) and BMS-986207 (NCT02913313; ± anti-PD-1 nivolumab) are two early phase potential immuno-oncology mAbs that prevent TIGIT-PVR interaction. OncoMed, Arcus Biosciences and Merck also have anti-TIGIT antibodies in their immuno-oncology pipelines (OMP-313M32/etigilimab, AB154/domvanalimab, and MK-7684 respectively) [469] ...
TIM3 (CD366)
(Other immune checkpoint proteins, CD molecules)
  • negative regulation of interferon-alpha production (GO:0032687) IDA
  • negative regulation of type II interferon production (GO:0032689) IDA
  • negative regulation of interleukin-2 production (GO:0032703) IDA
  • negative regulation of interleukin-3 production (GO:0032712) IDA
  • negative regulation of tumor necrosis factor production (GO:0032720) IMP
  • positive regulation of interleukin-4 production (GO:0032753) IMP
  • positive regulation of tumor necrosis factor production (GO:0032760) IMP
  • negative regulation of granulocyte colony-stimulating factor production (GO:0071656) IDA
  • negative regulation of interleukin-6 production (GO:0032715) IEA
  • positive regulation of chemokine production (GO:0032722) IEA
  • positive regulation of type II interferon production (GO:0032729) IEA
  • positive regulation of interleukin-1 production (GO:0032732) IEA
  • toll-like receptor 3 signaling pathway (GO:0034138) IEA
  • toll-like receptor 7 signaling pathway (GO:0034154) IEA
  • toll-like receptor 9 signaling pathway (GO:0034162) IEA
true TIM3 is an immunoglobulin type protein expressed exclusively on the surface of differentiated Th1 cells [372] ...
V-set immunoregulatory receptor
(Other immune checkpoint proteins)
  • negative regulation of type II interferon production (GO:0032689) IDA
  • negative regulation of interleukin-10 production (GO:0032693) IDA
  • negative regulation of interleukin-17 production (GO:0032700) IDA
  • negative regulation of tumor necrosis factor production (GO:0032720) IDA
true V-set immunoregulatory receptor (VSIR) is commonly referred to as VISTA in the literature corpus. This is an Ig superfamily (B7 family) protein that acts as an inhibitory immune-checkpoint molecule. In common with other T cell co-inhibitory receptors (e.g. CTLA-4, PD-1, TIM3, and LAG3) it is involved in maintaining peripheral tolerance [314] ...
X-linked inhibitor of apoptosis
(Inhibitors of apoptosis (IAP) protein family)
  • negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) IDA
  • positive regulation of type I interferon production (GO:0032481) IDA
  • regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0070424) TAS
  • nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427) IDA
  • nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431) IDA
true Mouse experiments suggest that XIAP regulates innate immune responses (to Listeria monocytogenes infection) by potentiating synergy between Toll-like receptors (TLRs) and NOD-like receptors (NLRs) through activation of JNK- and NF-κB-dependent signaling [41] ...